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In humans, washing stored blood products prior to transfusion reduces storage lesions
and the potential for transfusion reaction, but the effectiveness of washing units of canine whole
blood is unknown. The objective of this study was to determine if a manual method of washing
of stored whole blood units reduced storage lesions without adversely affecting erythrocytes.
Units of canine whole blood were stored for 28 days and manually washed three times with
sterile .9% NaCl. Following the first wash, there was a decrease in serum potassium (P<.0001),
lactate (P<.0001), pH (P=.0110), pCO2 (P<.0001), TCO2 (P<.0001), arachidonic acid (P<.0001),
and thromboxane B2 (P=.0417), and increases in iCa (P=.0494), iMg (P=.0024), MCV
(P<.0001), MCHC (P=.0093), RDW (P=.0009), hemoglobin (P=.0011), and MCF (P=.0006). No
bacterial growth was identified on the post-transfusion samples. Manual washing of stored blood
significantly reduces storage lesions after a single wash and additional washing may cause in
vitro hemolysis.
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CHAPTER I
LITERATURE REVIEW
Transfusions in Veterinary Medicine
The history of transfusion medicine in dogs dates back to the early 1600s and, in 1665,
Richard Lower performed the first canine transfusion when he drew blood from one dog and
replaced it with the blood from another dog1. After that, it was not until the mid-1900s and the
pressure of a world war, that transfusion medicine began to see progress with the development of
preservative additives and modern storage blood banking systems2. Over the last 40-50 years,
veterinary transfusion medicine has followed closely behind human transfusion medicine in
efforts to provide the most appropriate blood product to patients while reducing consequences of
transfusions3. Today, transfusions of whole blood or packed red blood cells (pRBCs) are
commonly used in the treatment of life-threatening anemia in critical veterinary patients4.
Initial efforts to progress transfusion medicine in dogs came about with the
standardization of canine blood types based on the presence of inherited erythrocyte cell surface
antigens. Detection and standardization efforts in the early 1970s5,6 resulted in which is now
widely recognized as dog erythrocyte antigens. There are currently several recognized classical
dog erythrocyte antigens (DEA)s: 1.1, 3, 4, 5, 7, 6 and 8. These antigens vary in their
immunogenicity and, thus, some like DEA 1.1 and DEA 7 are more clinically significant while
DEA 6 and 8 have no anti-DEA antibodies against them and have been determined to be
clinically insignificant7,8. DEA 1.1 have the highest incidence rate within the United States and
1

together make up over 60% of canine blood groups6,7,9. Donors that are negative for DEA 1.1, 3,
5, and 7, and positive for DEA 4 are considered to be universal canine blood donors; yet despite
this status this blood should not be considered universally safe8. Other unique canine blood
group systems have been described in veterinary hematology texts, including N-acetylneuraminic acid and N-glycolyl-neuraminic acid on RBC membranes of Kai, Kishi, Japanese
spaniels, Shiba dogs, and Japanese mongrels9. Another blood group identified in Akitas, Shiba,
Kishus, Shikous and Japanese mongrels is the D system blood group 9. A more recently
identified DEA-independent Dal erythrocyte antigen has been identified as being absent in
Dalmatians, Dobermann pinschers, and Shih Tzus10. Despite widely used mechanisms to type
and even crossmatch blood prior to transfusion, some recipients still develop life-threatening
reactions during and after blood transfusions11-13; making it clear that erythrocyte antigens are
not the only immunogenic component in blood products.
Transfusion Reactions in Dogs
Although transfusion is a necessary and frequently life-saving therapy, all transfusion
recipients, no matter the blood product, remain at risk for the development of adverse events and
severe, potentially life-threatening reactions. In veterinary medicine, over 10% of all blood
transfusion recipients are reported to develop a transfusion reaction3,11,14-16.
Transfusion reactions can occur through immunologic and non-immunologic
mechanisms17. Acute immunologic reactions include the most severe reactions: acute hemolytic
transfusion reactions. These occur when the recipient patient has existing antibodies to
erythrocyte antigens, and often occur when dogs are transfused mis-matched blood (or when
cross-matching was not performed) or had unknowingly been transfused previously allowing for
alloimmunization13,18. The ensuing reaction develops as a type II hypersensitivity reaction, in
2

which IgG or IgM antibodies bind donor red cells and activate complement resulting in
intravascular hemolysis in a dose-dependent manner13.
Allergic or type I hypersensitivity reactions can occur when antigens within donor blood
interact with IgE or IgG in recipients, resulting in mast cell and basophil degranulation13. A more
severe version of this reaction can occur when leukocytes within the unit of blood product
degranulate and release vasoactive substances that are then transfused into recipients resulting in
an anaphylactoid transfusion reaction13. Allergic reactions can be very mild, and their true
incidence in veterinary medicine is likely unknown, but anaphylactic transfusion reactions can be
difficult to distinguish in veterinary medicine from other allergic reactions13,17,19,20.
One of the most common transfusion reactions to occur in dogs is a febrile, nonhemolytic transfusion reaction12,13,15. This reaction is the result of leukocyte antigens present on
donor white blood cells and platelets that react with recipient antibodies upon transfusion. This
can result in increased concentrations of the cytokines interleukin 1beta (IL-1β), interleukin 6
(IL-6), interleukin 8 (IL-8) and tumor necrosis factor alpha (TNF-α) within the stored unit12,13,
and typically results in an elevated temperature of 1-2°C within 1-2 hours following a
transfusion 21.
The last of the acute immunologic reactions is transfusion-associated lung injury
(TRALI). This reaction is the result of leukocyte antibodies within the donor plasma against
recipient leukocytes causing leukocyte activation, usually within the lungs as a “second hit” after
previous priming of the leukocytes within the pulmonary vasculature. Clinical signs with this
reaction can occur 1-6 hours after transfusion of a plasma-containing blood product13, and can be
life threatening. The reported incidence of transfusion-associated lung injury in dogs is 3.7%;
much lower than the incidence reported in humans17,22.
3

Another common transfusion reaction in dogs is transfusion-associated circulatory
overload (TACO)23. As the name implies, this transfusion reaction occurs when large volumes of
products are provided to a patient such that they overwhelm the circulatory system13,17. This
reaction is not immunogenic in its origin, and is often treated by reducing the rate or the volume
of transfusions, and even by adding diuretic therapy4,13,13.
Non-immunogenic causes of transfusion reactions may occur as well, including
transmission of infectious diseases, citrate toxicity, hypothermia, and bacterial
contamination/sepsis13. Finally, delayed transfusion reactions are also reported in dogs,
including delayed hemolytic transfusion reactions, and post-transfusion purpura13,17.
With the potential for severe reactions, transfusions can carry with them the risk of
increasing morbidity and mortality in both veterinary patients and humans, alike. Thus, the focus
over the last few decades in transfusion medicine research has been on the identification of
causes of transfusion reactions as well as mechanisms for prevention of these reactions. As part
of this process, the consequences of blood product storage have come to the forefront. We now
recognize that the abnormal conditions created during ex vivo storage of units of blood can have
a significant impact on the microenvironment of the stored red cells and plasma. In fact, we now
know that while erythrocyte, leukocyte, and platelet metabolism is altered during cool storage,
metabolic and natural cellular processes continue, and can lead to the development of storage
lesions within the stored units of blood. These storage lesions may play a significant role in
transfusion reactions and patient outcome, and thus a great deal of human and veterinary
research has gone into their identification and prevention.
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Storage Lesions
Since the development of preservative products allowing for blood storage, blood
products can either be collected and immediately transfused, or stored in order to be readily
available for the next recipient. Both storage duration and environment can have a substantial
impact on RBC fragility and health. The changes that occur in units of stored blood are known
as “storage lesions”, and can create biochemical, biomechanical, and immunologic events24,25
that result in oxidative damage to erythrocytes and metabolic impairments26. In human medicine,
red cell storage lesions are being increasingly identified in transfusion-related issues27.
Impaired Erythrocyte Metabolism
Storage causes a decline of erythrocyte 2,3-diphospholgycerate (2,3-DPG), with a
decrease to below 54% of prestorage values within just 24 hours of storage of canine blood28,
and a decrease to below detectable limits in human blood products within 14 days for storage at
4oC29.The depletion of 2,3-DPG promotes the left shift of the oxygen-hemoglobin dissociation
curve; thereby increasing the affinity for oxygen to hemoglobin and preventing unloading of
oxygen in the tissues: this process has been suggested as a potential cause of increased patient
morbidity and mortality post-transfusion29. However, this process may primarily be a theoretical
consequence, as studies have not supported a significant change in tissue oxygenation posttransfusion30, and levels of 2,3-DPG are restored to normal within 72 hours of transfusion31.
Additionally, some veterinary species, like cats, do not depend on 2,3-DPG to increase
hemoglobin affinity32.
Storage also results in a 60% decrease in intracellular RBC ATP after 5 weeks of storage
of human blood29. The decline in ATP leads a myriad of metabolic derangements and
complications within the unit of blood, including oxidation of hemoglobin, proteins, and lipids26
5

that can result in alterations in red cell morphology and deformability33, increased red cell
hemolysis, increased cell free hemoglobin29, decreased pH with increased lactic and pyruvic
acids34, failure of enzymatic activity, and the formation of reactive oxygen species24, 35-37. In
particular, Na-K-ATPase in humans is an ATP dependent enzyme that helps to pump potassium
into the cell, and sodium out of the cell, and has diminished function under colder temperature or
in the ATP-depleted environments created by product storage38. In humans, plasma potassium
concentrations can increase significantly throughout storage, and can be a critical storage lesion
that must be addressed prior to the transfusion of neonates and infants undergoing cardiothoracic
surgery or in those receiving massive transfusions39. In most dogs, however, the Na-K-ATPase
enzyme is not as active, and therefore intraerythrocytic potassium concentrations do not reach
near the level as they do in humans32, and thus the concern for transfusion-induced hyperkalemia
is practically non-existent. However, there are several breeds of Japanese and Korean dogs (like
Akitas) that have increased activity of Na-K -ATPase40 whose stored blood product, if these
breeds are used as donors, could result in significantly elevated plasma potassium concentrations
and may therefore pose a risk during transfusions.
Oxidative Damage to Erythrocytes
Oxidative damage and the exposure of red cells to abnormal levels of oxygen during
storage as oxygen seeps into the unit of blood is one of the most important mechanisms of
storage lesion development26. Oxidation of hemoglobin can result in the release of cell free
hemoglobin that can be oxidized and lead to the subsequent development of superoxide and other
reactive oxygen species32. As ATP and glutathione levels are depleted, these reactive oxygen
species can oxidize proteins and lipids and wreak havoc on stored red cells41. Oxidized proteins
become denatured, aggregate, or precipitate out of solution, resulting in damaged cellular
6

membranes and cytoskeletons, altered surface proteins, with resultant activation of advanced
glycation end products that can be harmful to cells, increase reactive oxygen species, and
increase inflammation26.
Eicosanoids as Storage Lesions
The oxidation of lipids and polyunsaturated fats in stored blood has been investigated by
our research group within the last decade. Along with linolenic acid and docosahexaenoic acid,
arachidonic acid levels have been documented to increase significantly through human blood
storage42. Furthermore, eicosanoids like prostaglandin F2α (PGF2α), thromboxane B2 (TXB2), 6keto-prostaglandin F1α (6-keto-PGF1α), leukotriene B4 (LTB4), hydroxyeicosatetraenoic acids
(HETEs), and hydroxyoctadecadienoic acids (HODEs) have been documented to increase during
storage of both human and canine blood products42,43. These are bioactive molecules derived
from arachidonic acid that have been noted to be present at variable levels in donor blood
products, but all can increase throughout storage42 and have been theorized to increase the risk of
transfusion reactions44-46.
Leukocytes within the stored unit of blood are thought to be the primary source of these
eicosanoids41,47. Cyclooxygenase 1 (COX1) expression on platelets primarily promotes
thromboxane formation, while cyclooxygenase (COX2) expression in leukocytes favor the
formation of prostaglandins47,48. In a study by Fu et al. in 2016, researchers surmised that a lack
of prostaglandin detection within stored human blood product was likely due to little to no
leukocyte COX2 activity42. This can be a source of variability not only from one donor to the
next, but also between species. In fact, while the previously mentioned study did not detect levels
of any prostaglandin, a different study on murine stored blood not only detected prostaglandins
in stored blood but also demonstrated increased levels of many eicosanoids (PGE2, 5-HETE, 127

HETE, 15-HETE, 13-HODE and 9-HODE) throughout storage49. This highlights the need to
further investigate storage lesions within each individual species.
Erythrocytes have been described as a one potential source of eicosanoid synthesis42,50,51.
RBCs synthesize eicosanoids from the arachidonic acid that is released by phospholipase A2
from the cellular phospholipid membrane48,52. Phospholipase A2 can be activated by hormones,
cytokines, mechanical injury53 and even decreased temperatures seen with blood storage54.
Erythrocytes can also produce HETEs and HODEs through the nonenzymatic lipid peroxidation
pathways of arachidonic acid and linolenic acid, respectively42. Studies that have removed
leukocytes through a process called leukoreduction have further demonstrated increases in
eicosanoids, HETEs and HODEs throughout storage, regardless of leukoreduced states,
suggesting a role of other remaining cells such as erythrocytes42.
The full clinical significance of eicosanoids as storage lesions has not been entirely
elucidated yet, but there have been human and animal studies demonstrating their importance. In
one murine study, stored mouse blood generated increased levels of HETEs and HODEs, and the
increase in these eicosanoids was associated with poor recovery in mice post-transfusion49.
Additionally, arachidonic acid and HETEs have been implicated as the “second hit” in the twohit model for TRALI41. Other clinical consequences of exposure to increased eicosanoids include
the immunomodulatory effects of PGE255, bolstering of systemic inflammatory response
syndrome (SIRS) responses by leukotrienes and thromboxanes56-60, and leukocyte and platelet
activation by thromboxanes61,62. Thromboxanes and HETEs mediate vasoconstriction and, in this
way, transfusion of eicosanoids have been theorized to generate vascular effects on recipients,
but this has not been clinically demonstrated63,64. Further investigation into the effects of
eicosanoids as storage lesions and their physiologic effects on transfusion recipients is needed.
8

Microparticles & Hemolysis
Oxidation of erythrocytic lipids does not just lead to eicosanoid formation; it can also
result in the vesiculation of red cell membrane phospholipids, including exposed
phosphatidylserine, leading to increased microparticles within units of stored blood cells52. The
budding of the membrane to form microparticles in vivo is a protective mechanism for
erythrocytes, as the microparticles would be subsequently removed from circulation by the
reticuloendothelial system65. Depletion in ATP availability no longer prevents cell surface
expression of phosphatidylserine, a surface marker that promotes macrophage clearance of red
cells post-transfusion32,41,66,67. In storage, microparticle formation can have significant
consequences. Microparticles can lead to procoagulant activity by allowing for exposure of
negatively charged phosphatidylserine that promotes thrombin formation through tenase and
prothrombinase activity68. The microparticles can also have procoagulant activity through their
expression of tissue factor69 and increasing adherence of leukocytes to vascular endothelium65,
and the microparticles can also be pro-inflammatory once transfused by promoting cytokine
release70. This has prompted research in the veterinary fields into methods for microparticle
detection and easier ways for quantification71.
Some of the earliest storage lesions described were progressive changes in RBC shape,
with development of echinocytes and then ultimately irreversible change to spheroechinocytes or
spherocytes33,72,73. Additionally, as cell health declines in stored units, there is increased risk of
erythrocyte lysis and release of cell free hemoglobin29,33. This phenomenon can pose a
significant health risk to the patient: as an example, Patterson et al. reported the death of three of
four dogs that developed an acute hemolytic reaction due to inappropriate storage of red blood
cell products25.Transfusion of stored blood with high concentrations of cell free hemoglobin can
9

have detrimental physiologic effects on the recipient, not only due to transfusion reactions but
also through direct effects on vascular nitric oxide availability and bacterial metabolism. Nitric
oxide (NO) is produced in vivo by vascular endothelial cells, and its primary role is local
vasodilation74. Other important roles of NO include inhibition of platelet aggregation and
expression of adhesion molecules, demonstrating that scavenging of NO could result in increased
risk of thromboembolic events, increased leukocyte adhesion and diapedesis, and increased
endothelial permeability74. When stored blood with increased concentrations of cell free
hemoglobin are transfused into patients, the natural buffering mechanism for excess hemoglobin,
haptoglobin, becomes rapidly overwhelmed. Residual hemoglobin is instead able to interact with
and scavenge nitric oxide resulting in vascular dysfunction within the recipient74. Consequences
of this depletion of NO by cell free hemoglobin were previously demonstrated in a study by
Solomon et al. that showed significant vasoconstriction and improved patient outcome in models
of canine hypovolemic shock with dogs that had increased levels of NTIB and cell free
hemoglobin75. In a veterinary review on storage lesions, a large focus was on the consequences
of free hemoglobin or iron, and on their scavenging effects24.
Other Storage Lesions
In humans, it has been shown that, as well as contributing to red cell fragility, the act of
storing blood products leads to the accumulation of cytokines such as IL-1β, IL-6, and IL-844,76.
Accumulation of these molecules is believed to significantly increase the risk of transfusion
reactions45. Storage of canine blood products appears to lead to accumulation of the same classes
of molecules that are observed with stored human products. Recent work by Corsi and others
documented a significant increase in the pro-inflammatory cytokine IL-8 in units of stored
canine pRBCs46.
10

A 2001 study investigated the accumulation of ammonia in canine packed red blood cells,
and found that ammonia concentrations increased during storage77. The ammonia was suspected
to be secondary to the deamination of amino acids within the red cell units, as well as breakdown
of purines that are components of the preservative solutions77. The dogs that were transfused
pRBCs with increased ammonia levels, but did not have increased levels of ammonia in
circulation post-transfusion77. The authors of this study suggested that this indicated that healthy
dogs can metabolize this storage lesion, but that it was possible that dogs with liver dysfunction
could be negatively affected by the excess ammonia source in stored blood products77.
Documented Consequences of Storage Lesions
The extent of storage lesion development is still being heavily researched, as are the
consequences of those storage lesions in patients. There is wide debate on whether the
transfusion of older blood increases morbidity in transfusion recipients. A retrospective
evaluation of red cell product age on transfusion-related complications in dogs revealed an
increased risk of hemolysis (odds ratio 1.11) with each additional day of age of storage78. Yet, in
this study, and another study, transfusion of dogs with older blood products was not associated
with increased mortality78,79, although it is possible that the study performed by Holowaychuk et
al was underpowered79. In human pediatric cardiac surgery patients, red cell storage age was also
not associated with adverse events80. Additionally, in one study of hemorrhagic shock in dogs,
transfusion of older blood was actually associated with an improved outcome, with reduced
mortality rates and decreased norepinephrine requirements75. The benefits the use of older blood
in this study were attributed to the vasoconstrictive effects of cell free hemoglobin through the
scavenging of NO75. Certainly, it is possible that in some circumstances, transfusion of older

11

blood with associated storage lesions may prove beneficial or even lifesaving in patients. Further
investigation into this area is recommended.
There are, however, an abundance of literature reviews highlighting storage lesions in
humans and dogs, and the association between these storage lesions and negative consequences
or outcomes24,26,81-83. The length of storage has been demonstrated to contribute to a negative
case outcome in dogs with hemolysis or immune-mediated hemolytic anemia15. Human trauma
patients have an increased risk of multiple organ failure when receiving blood that is stored for
longer than 14 days (odds ratio 1.16), with even greater risk of multiple organ failure with stored
blood that is older than 21 days (odds ratio 1.22)84. In a study using canine models of pneumonia,
researchers transfused dogs with blood of variable storage age, and found that transfused dogs
with pneumonia had increased cell free hemoglobin, increased free iron in the form of nontransferrin bound iron (NTBI), and decreased haptoglobin levels if they were transfused with
older stored blood compared to those that were transfused with fresh blood85. Additionally, those
dogs transfused with older blood developed in vivo hemolysis of transfused blood, had increased
mortality rates, and worsening lung damage on histopathology85, and the authors of this study
proposed that increased free iron likely provided a critical nutrient for bacterial growth, allowing
for pneumonia to worsen in these patients. Additionally, scavenging of NO can lead to profound
vasoconstriction that results in systemic and pulmonic hypertension, induced ischemia, and
vascular endothelial injury with the transfusion of older blood85,86. A second study was
performed by the same research group, using the same canine model in which dogs with
pneumonia were challenged with bacteria after receiving transfusions of either old stored blood
or fresh blood87. In this second study, the researchers found not only the expected increase in cell
free hemoglobin in animals that received older blood, but also a more rapid and greater decline
12

in NTBI and worsening sepsis87. In a study using autologous transfusions in dogs, dogs that were
transfused older blood had elevated total iron binding capacity, labile iron hemoglobin and
ferritin, with concurrent decreases in transferrin and haptoglobin88. In general, increasing iron
availability by any means to anemic dogs with infections has been demonstrated to increase
morbidity: anemic dogs exhibited increased shock, increased lung injury and increased NTBI
after intravenous iron was supplemented in dogs with experimental bacterial pneumonia89.
Overall, it is becoming increasingly clear that the length of storage of blood product
increases the degree of storage lesions, thus potentially increasing the risks associated with
transfusion, at least in some clinical circumstances such as hemolysis and pneumonia.
Current Methods to Reduce Storage Lesions
Several methods have been used to reduce the accumulation of storage lesions, improve
erythrocyte health, prolong RBC survival in the recipient, and reduce the risk and severity of
transfusion reactions. Advancements in cell preservative solutions and additives90, transfusion
techniques91,92, and ideal storage temperatures93 have improved erythrocyte health and prolonged
the safe duration of storage, but have not completely eliminated the development of storage
lesions26.
Leukoreduction and platelet depletion filters to extract leukocytes and platelets from the
unit prior to storage can be utilized in an attempt to prevent these cells from influencing the
microenvironment within the unit by producing and releasing inflammatory mediators during
storage94,95. Leukoreduction has the proven benefits of reducing storage lesions including
cytokines46,76,96 and microparticles66 by removing leukocytes and platelets that can retain some
level of activity within stored units of blood and that thereby may contribute to storage lesion
development. Compared to dogs that receive leukoreduced blood, dogs that receive non13

leukoreduced blood have increased total white blood cell counts 2-24 hours after transfusion97,98,
with increased segmented neutrophils, increased fibrinogen levels, and elevated C reactive
protein98.
Leukoreduction is not without its limitations. In dogs, pre-storage leukoreduction and
platelet depletion causes an immediate increase in concentrations of thromboxane B2 and
PGF2α99 and, in humans, leukoreduction results in an immediate increase in supernatant
potassium levels that may be associated with platelet activation or hemolysis100 as well as an
increase in IL-645. Additionally, in dogs, leukoreduction does not prevent the accumulation 6keto-PGF2α99 and, in humans undergoing radical prostatectomies, other eicosanoids like PGE2,
TXB2, and the cytokine IL6 were not reduced by leukoreduction45. Additionally, leukoreduction
filters do not prevent the survival of some organisms, such as Rickettsia conorii101, in
experimentally infected canine blood products. In healthy dogs regardless of their leukoreduced
status, transfusion of older blood products still induces an inflammatory response as
characterized by increased monocyte chemoattractant protein 1, increased neutrophil counts,
decreased platelets, increased NTBI, and evidence of intravascular hemolysis102.
Rejuvenation techniques that are meant to improve red cell health just prior to
transfusion have shown some promise103. This technique involves storing blood in solutions rich
in inosine or adenine to help restore ATP and 2,3-diphosphoglycerate concentrations within the
units, and then removing the solution and remaining plasma through a washing step prior to
transfusion103. Transfusions of rejuvenated red cells have been shown to be effective in reducing
cell free hemoglobin, leukocyte sequestration, lung injury, kidney injury, and endothelial
dysfunction in pigs transfused stored blood103.
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An alternative method evaluated for the potential to reduce storage lesions or transfusion
reactions is irradiation and UV-irradiation of canine units of blood products104,105. Irradiation,
however, results in increased levels of potassium, lactate, and cell free hemoglobin, with
concurrent decrease in pH104. Irradiation has also been associated with increased IL-8 by day 14
of storage post-radiation in canine whole blood96. Long-term storage of canine blood products by
freezing has also been reported106,107 and, in a recent study, freezing erythrocytes showed no
negative effect on 2,3-DPG, ATP, free hemoglobin, sodium, potassium, and hemograms106.
With all these different reported methodologies, however, units of stored blood still had
storage lesions such as vasoactive molecules that may be transfused into the recipient. An
alternative methodology that would be expected to lead to the near total elimination of these
vasoactive molecules, such as red blood cell washing immediately prior to transfusion, has the
potential to significantly reduce the risk of transfusion reactions.
Red Cell Washing
Introduction to Washing
One method of reducing storage lesions is washing the units of red cells prior to
transfusion. Washing of red blood cells prior to transfusion is a technique that effectively
removes between 95 and 99.9% of the plasma/supernatant within the unit, including plasma
components such as proteins, electrolytes (including potassium), microparticles, antibodies,
cellular debris, and other storage lesions that have accumulated in the unit during storage108. The
process can be performed through manual washing techniques, or through the use of automated
washing devices109,110. There have been studies in human medicine that have investigated the
efficacy of manual versus automated techniques, and have found that manual techniques do a
better job at removing plasma protein levels and clearing residual plasma110,111. Additional
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exploration into the washing of human blood products has evaluated whether it is better to
perform the washing just before transfusion (“in the operating room”) or at blood storage
facilities (“in the blood bank”), and confirmed greater reduction of storage lesions with washing
as close to administration as possible (that is, in the operating room) because of a greater ability
to reduce cell free hemoglobin and lactate dehydrogenase levels109. A proof-of-concept study has
developed a novel technique that washes red cells bedside as the transfusion occurs112, but this
technique will require further development before it is readily available in human medicine, let
alone in veterinary medicine.
Washing Media
One final area being investigated in red cell washing is an effort to identify the ideal
washing medium that supports red cell health111,113,114. Studies have investigated the use of
saline-adenine-glucose-mannitol (SAGM), 0.9% saline, saline-glucose mixtures, PlasmaLyte®,
5% albumin products, and deglycerolization media, all with variable results, and no cross-over in
interpretation between studies can be gleaned111,113,114. Specifically, when compared to saline in
automated washers, PlasmaLyte® resulted in higher levels of potassium and lower levels of
sodium within the human units of blood114. In a 3-way comparison, SAGM resulted in less
hemolysis and decreased microparticles/ microvesicles compared to saline or saline glucose
mixtures as washing media111.
Storage Lesion Reduction with Washing
Washing red cells has been proven to reduce storage lesions such as cell free
hemoglobin87,115, potassium39,103,116-119, IgA, total protein, lactate, cytokines, cell surface proteins
like E-selectin and CD106116, and eicosanoids within the red cell supernatant42. The use of
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washed RBCs has reduced transfusion reactions86 and decreased the risk of transfusionassociated lung injury in humans120. Cholette et al. showed that washing of red cell components
prior to transfusion decreased systemic inflammatory mediators, IL-6, IL-6:IL-10 ratios, and C
reactive protein levels in children undergoing cardiac surgery, and resulted in a need for a lesser
number of transfusions121.
Currently, the effects of pre-transfusion washing of blood products in dogs is mostly
unknown. However, using a canine pneumonia model, the use of washed pRBCs prior to
transfusion reduced multiple organ injury and improved survival rates compared to non-washed
blood products115, suggesting that pre-transfusion washing may benefit dogs receiving blood
products.
Although the use of washed blood products would be expected to decrease storage
lesions and reduce the risk of transfusion reactions, the simple act of washing itself could cause
some unintended consequences. One such consequence is erythrocyte swelling. The cellular
swelling during washing is widely considered to be secondary to build up of osmotically active
substances (such as lactate, chloride, and 2,3-DPG) intracellularly32,34. These osmotically active
substances develop during storage and, after washing, the extracellular osmolality decreases
significantly depending on the washing media used120,122, potentially resulting in an intracellular
shift of fluid. Additionally, the storage-related dysfunction of Na-K-ATPase that causes an
increase concentration of intracellular sodium may also lead to an osmotic pull of water into the
RBC and cell swelling24,38,123.
Increased MCV due to erythrocyte swelling shortens the lifespan of erythrocytes and
increases osmotic fragility due to the decreased surface area to volume ratio and decreased
deformability34,123. Washing RBCs could, for example, increase RBC fragility and lead to
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hemolysis during or after transfusion108. Grabmer et al., for example, reported an increase in
hemolysis following washing, but the degree of hemolysis remained less than 0.8%, the
maximum level of accepted hemolysis recommended by the Council of Europe116. Loh et al. also
demonstrated a minor increase in hemolysis and a minor loss of red cells during washing124.
Finally, Weisbach et al. showed a significant loss of 2,3-DPG levels in washed RBCs compared
to non-washed RBCs, especially in older erythrocytes125.
The normal plasma osmolality in dogs is approximately 300mOsm/L and with the
addition of the storage media, and then subsequently throughout storage, plasma osmolality
would be expected to increase, potentially resulting in echinocyte formation. Washing media like
those widely used in human and veterinary medicine often have different osmolalities than that
of normal canine plasma. Lactated Ringer’s solution has an osmolality of 273 mOsm/L while
normal saline has an osmolality of 308 mOsm/L. As mentioned above, washing with normal
saline can results in cellular swelling of stored erythrocytes and so researchers have explored
washing human red cells with solutions containing dextrose, mannitol, or albumin that exhibit
osmotic or colloidal oncotic effects111,113,122,125. Findings from those studies revealed improve red
cell morphology as evidenced by normalized MCV and increased MCHC, as well as decreased
erythrocyte water content and improved cell health111,113,122,125. No studies in veterinary patients
have looked at the optimal washing media for canine stored red cells.
Methods for Erythrocyte Washing
Washing red cells within blood units can be performed by multiple techniques that include an
automated closed system, centrifugation techniques, or mechanical washing with an open
system. All these techniques suspend the red cells in saline or other isotonic/ preservative
fluids108. Automated closed systems that wash units of blood prior to transfusion can be
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expensive, and are not readily available in veterinary hospitals. Therefore, if washing of blood
products is going to be utilized in veterinary clinics, manual techniques will almost certainly be
the most common method used. Because manual washing techniques are largely unexplored in
veterinary medicine, and methodology must be extrapolated from human medicine, the most
appropriate protocols for use in dogs are unknown.
Currently, it is unknown how many washes are needed for canine blood units, the ideal
washing solution, the appropriate centrifugation speed and time, or even the optimal time
allowed for storage after washing. In humans, there are several washing techniques that have
been investigated for the purposes of comparing automated washing versus manual washing in
terms of efficacy of reducing storage lesions111,114, but no such studies have been reported in
dogs. The general techniques for manual washing of human stored red cells involve performing
three washes with the wash media124,125, but reported studies of washing canine red cells have
used automated washers86,115,126, and no investigation has therefore looked into the best number
of manual washes for canine stored red cells. Even the centrifugation speed and time for manual
washing techniques is variable, with reported speeds between 2900×g to 4950×g, and times
ranging from 5 to 15 minutes for each wash step111,124,125. There is still a great deal more to
uncover in veterinary transfusion medicine with regards to the washing of stored canine red cell
units.
The use of pre-transfusion washed red blood cell products has the potential to reduce storage
lesions and prevent transfusion reactions in veterinary patients, especially, based on the human
experience, in smaller dogs and cats, neonates, and patients that require multiple or massive
transfusions. The long-term goal of our research group is to establish blood transfusion protocols
that allow veterinarians to select safer blood products and potentially minimize the frequency
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and severity of transfusion reactions. The objectives of the study described in this thesis are to
determine if a manual method of washing units of canine whole blood can be performed without
causing adverse effects to erythrocytes, and to determine if this technique will effectively reduce
storage lesions, including levels of vasoactive prostaglandins and leukotrienes, that accumulate
in blood products during storage and transfusion. The study hypotheses were that the washing
protocol could be performed without causing significant damage to the washed erythrocytes, and
that a single wash could significantly reduce the amount of vasoactive substances and other
potentially harmful molecules that accumulate in units of canine whole blood. Because
veterinarians use stored blood products more frequently than fresh blood as a life-saving therapy
in critical patients127, the development of a simple manual washing protocol that can safely
reduce the risk of transfusion reactions has the potential to have an immediate impact on the
clinical use of stored blood products, and to assist clinicians with therapeutic decision-making
when treating patients in need of a blood transfusion.

20

References
1.

Lower R. The method observed in transfusing the bloud out of one animal into another.
Philos Trans. 1665;1:353–358. http://www.jstor.org/stable/101528.

2.

Cotter SM. History of transfusion medicine. Adv Vet Sci Comp Med. 1991;36:1–8. doi:
10.1016/b978-0-12-039236-0.50006-0.

3.

Callan MB. Red blood cell transfusion in the dog and cat. In: Weiss DJ, Wardrop KJ, eds.
Schalm's Veterinary Hematology. 6th ed. Hoboken, NJ: Wiley- Blackwell, 2010: 738742.

4.

Davidow B. Transfusion medicine in small animals. Vet Clin North Am Small Anim
Pract. 2013;43(4):735-756. doi:10.1016/j.cvsm.2013.03.007

5.

Vriesendorp HM, Westbroek DL, D’Amaro J, et al. Joint report of 1st international
workshop on canine immunogenetics. Tissue Antigen. 1973; 3: 145 – 172. PMID:
4274159.

6.

Vriesendorp HM, Albert ED, Templeton JW, et al. Joint report of the second
international workshop on canine immunogenetics. Transplant Proc.1976;8:289 – 314.
PMID: 942618.

7.

Hale AS. Canine blood groups and their importance in veterinary transfusion medicine.
Vet Clin N Am Small Anim Pract. 1995;25:1323 – 1332. doi: 10.1016/s01955616(95)50157-3.

8.

Hohenhaus A. Importance of blood groups and blood group antibodies in companion
animals. Transfus Med Rev. 2004;18(2):117–126. doi: 10.1016/j.tmrv.2003.12.003.

9.

Andrews GA, Penedo MCT. Erythrocyte antigens and blood groups. In: Weiss DJ,
Wardrop KJ, eds. Schalm's Veterinary Hematology. 6th ed. Hoboken, NJ: WileyBlackwell, 2010:711-722.

10.

Blais MC, Berman L, Oakley DA, et al. Canine Dal blood type: A red cell antigen
lacking in some dalmatians. J Vet Intern Med 2007; 21: 281 – 286. doi: 10.1892/08916640(2007)21[281:cdbtar]2.0.co;2.

11.

Lanevschi A, Wardrop KJ. Principles of transfusion medicine in small animals. Can Vet
J. 2001 Jun;42(6):447-54. PMID: 11424576; PMCID: PMC1476557.

12.

Tocci LJ. Transfusion medicine in small animal practice. Vet Clin North Am Small Anim
Pract. 2010;40(3):485-494. doi:10.1016/j.cvsm.2010.02.005

13.

Bracker KE, Drellich S. Transfusion reactions. Compend Contin Educ Pract Vet.
2005;27:500–512.
21

14.

Callan MB, Oakley DA, Shofer FS, et al. Canine red blood cell transfusion practice. J
Am Anim Hosp Assoc. 1996;32:303–311. doi: 10.5326/15473317-32-4-303.

15.

Hann L, Brown DC, King LG, et al. Effect of duration of packed red blood cell storage
on morbidity and mortality in dogs after transfusion: 3,095 cases (2001–2010). J Vet
Intern Med 2014;28:1830–1837. doi: 10.1111/jvim.12430.

16.

Kerl ME, Hohenhaus AE. Packed red blood cell transfusions in dogs: 131 cases (1989). J
Am Vet Med Assoc 1993;202:1495–1499. PMID: 8496108.

17.

Weinstein NM. Transfusion reactions. In: Weiss DJ, Wardrop KJ, eds. Schalm's
Veterinary Hematology. 6th ed. Hoboken, NJ: Wiley- Blackwell, 2010:769-774.

18.

Goy-Thollot I, Giger U, Boisvineau C, et al. Pre- and post-transfusion alloimmunization
in dogs characterized by 2 antiglobulin-enhanced cross-match tests. J Vet Intern Med.
2017;31(5):1420-1429. doi:10.1111/jvim.14801

19.

Smith MR, Wurlod VA, Ralph AG, et al. Mortality rate and prognostic factors for dogs
with severe anaphylaxis: 67 cases (2016–2018). J Am Vet Med Assoc.
2020;256(10):1137-1144. doi:10.2460/javma.256.10.1137

20.

Shmuel DL, Cortes Y. Anaphylaxis in dogs and cats. J Vet Emerg Crit Care.
2013;23(4):377-394. doi:10.1111/vec.12066

21.

Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion 2012;
52(Suppl):65S–79S.

22.

Thomovsky EJ, Bach J. Incidence of acute lung injury in dogs receiving transfusions. J
Am Vet Med Assoc. 2014;244(2):170-174. doi:10.2460/javma.244.2.170

23.

Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after
plasma transfusion. Transfusion 2012;52(1):160–5. doi: 10.1111/j.15372995.2011.03247.x.

24.

Obrador R, Musulin S, Hansen B. Red blood cell storage lesion. J Vet Emerg Crit Care.
2015;25(2):187-199. doi:10.1111/vec.12252

25.

Patterson J, Rousseau A, Kessler RJ, et al. In vitro lysis and acute transfusion reactions
with hemolysis caused by inappropriate storage of canine red blood cell products. J Vet
Intern Med. 2011;25(4):927-933. doi:10.1111/j.1939-1676.2011.0737.x

26.

Yoshida T, Prudent M, D’Alessandro A. Red blood cell storage lesion: causes and
potential clinical consequences. Blood Transfus. 2019;17(1):27-52.
doi:10.2450/2019.0217-18

22

27.

Pavenski K, Saidenberg E, Lavoie M, et al. Red blood cell storage lesions and related
transfusion issues: a Canadian Blood Services research and development symposium.
Transfus Med Rev. 2012 Jan;26(1):68-84. doi: 10.1016/j.tmrv.2011.07.003.

28.

Price GS, Armstrong J, McLeod DA, et al. Evaluation of citrate-phosphate-dextroseadenine as a storage medium for packed canine erythrocytes. J Vet Intern Med. 1988 JulSep;2(3):126-32. doi: 10.1111/j.1939-1676.1988.tb02808.x.

29.

Raat NJ, Ince C. Oxygenating the microcirculation: the perspective from blood
transfusion and blood storage. Vox Sang. 2007; 93, 12–18. doi: 10.1111/j.14230410.2007.00909.x

30.

Raat NJ, Verhoeven AJ, Mik EG, et al. The effect of storage time of human red cells on
intestinal microcirculatory oxygenation in a rat isovolemic exchange model. Crit Care
Med. 2005 Jan;33(1):39-45. doi: 10.1097/01.ccm.0000150655.75519.02.

31.

Heaton A, Keegan T, Holme S. In vivo regeneration of red cell 2,3-diphosphoglycerate
following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J
Haematol. 1989 Jan;71(1):131-6. doi: 10.1111/j.1365-2141.1989.tb06286.x.

32.

Harvey JW. Erythrocyte biochemistry. In: Weiss DJ, Wardrop KJ, eds. Schalm's
Veterinary Hematology. 6th ed. Hoboken, NJ: Wiley- Blackwell, 2010:131-135.

33.

Hess JR, Sparrow RL, van der Meer PF, et al. Red blood cell hemolysis during blood
bank storage: using national quality management data to answer basic scientific
questions. Transfusion. 2009 Dec;49(12):2599-603. doi: 10.1111/j.15372995.2009.02275.x.

34.

Beutler E. Liquid preservation of red cells, In: Rossi E, Simon T, Moss G, et al. eds.
Principles of Transfusion Medicine. 2nd edn. Baltimore, MD: Williams & Wilkins; 1996,
pp. 51–60.

35.

Picas L, Rico F, Deforet M, et al. Structural and mechanical heterogeneity of the
erythrocyte membrane reveals hallmarks of membrane stability. ACS Nano 2013;
7(2):1054–1063. doi: 10.1021/nn303824j

36.

Birka C, Lang PA, Kempe DS, et al. Enhanced susceptibility to erythrocyte “apoptosis”
following phosphate depletion. Pflugers Arch 2004; 448(5):471–477. doi:
10.1007/s00424-004-1289-y

37.

Tavazzi B, Di PD, Amorini AM, et al. Energy metabolism and lipid peroxidation of
human erythrocytes as a function of increased oxidative stress. Eur J Biochem 2000;
267(3):684–689.

38.

Makhro A, Huisjes R, Verhagen LP, et al. Red cell properties after different modes of
blood transportation. Front Physiol. 2016;7:288. doi:10.3389/fphys.2016.00288
23

39.

Cholette JM, Pietropaoli AP, Henrichs KF, et al. Longer RBC storage duration is
associated with increased postoperative infections in pediatric cardiac surgery. Pediatr
Crit Care Med. 2015;16(3):227-235. doi:10.1097/PCC.0000000000000320

40.

Fujise H, Higa K, Nakayama T, et al. Incidence of dogs possessing red blood cells with
high K in Japan and East Asia. J Vet Med Sci. 1997 Jun;59(6):495-7. doi:
10.1292/jvms.59.495

41.

Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop
during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin
Med 1994; 124(5):684– 694. PMID: 7964126.

42.

Fu X, Felcyn JR, Odem-Davis K, et al. Bioactive lipids accumulate in stored red blood
cells despite leukoreduction: a targeted metabolomics study. Transfusion.
2016;56(10):2560-2570. doi:10.1111/trf.13748

43.

Blake RR, Lee JH, Ross MK, et al. Evaluation of eicosanoid concentrations in stored
units of canine packed red blood cells. J Am Vet Med Assoc. 2017;250(2):191-198.
doi:10.2460/javma.250.2.191

44.

Jacobi K, Walther A, Lörler H, et al. Plasma levels of eicosanoids after transfusion of
intraoperatively salvaged blood. Vox Sang. 2000;78(1):31-36. doi:10.1159/000031146

45.

Jacobi KE, Wanke C, Jacobi A, et al. Determination of eicosanoid and cytokine
production in salvaged blood, stored red blood cell concentrates, and whole blood. J Clin
Anesth. 2000;12(2):94-99. doi:10.1016/S0952-8180(00)00122-7

46.

Corsi R, McMichael MA, Smith SA, et al. Cytokine concentration in stored canine
erythrocyte concentrates. J Vet Emerg Crit Care. 2014;24(3):259-263.
doi:10.1111/vec.12160

47.

Bogatcheva NV, Sergeeva MG, Dudek SM, et al. Arachidonic acid cascade in endothelial
pathobiology. Microvasc Res. 2005 May;69(3):107-27. doi: 10.1016/j.mvr.2005.01.007.

48.

Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology
and immunopathology. Trends Mol Med. 2008 Oct;14(10):461-9. doi:
10.1016/j.molmed.2008.08.005.

49.

Zimring JC, Smith N, Stowell SR, et al. Strain-specific red blood cell storage,
metabolism, and eicosanoid generation in a mouse model. Transfusion. 2014;54(1):137148. doi:10.1111/trf.12264

50.

Fitzpatrick F, Liggett W, McGee J, et al. Metabolism of leukotriene leukotriene A4 by
human erythrocytes. A novel cellular source of leukotriene B4. J Biol Chem. 1984 Sep
25;259(18):11403-7. PMID: 6088544.

24

51.

McGee JE, Fitzpatrick FA. Erythrocyte-neutrophil interactions: formations of leukotriene
B4 by transcellular biosynthesis. Proc Natl Acad Sci USA. 1986;83(5):1349-1353.
doi:10.1073/pnas.83.5.1349

52.

Oliver CS, Andrews GA, Smith JE, et al. Erythrocyte Structure and Function. In: Weiss
DJ, Wardrop KJ, eds. Schalm's Veterinary Hematology. 6th ed. Hoboken, NJ: WileyBlackwell, 2010:123-129.

53.

Pinson A, Halabi A, Shohami E. Mechanical injury increases eicosanoid production in
cultured cardiomyocytes. Prostaglandins Leukot Essent Fatty Acids. 1992 May;46(1):913. doi: 10.1016/0952-3278(92)90052-k.

54.

Majumdar R, Gowda D, Brooke MH. Evidence of a temperature-sensitive step in the
release of prostaglandin E2 in calcium ionophore stimulated rat muscle. Prostaglandins
Leukot Essent Fatty Acids. 1995 Aug;53(2):117-22. doi: 10.1016/0952-3278(95)901388.

55.

Dennis F, Landers, DF, Gary EH, et al. Blood transfusion-induced immunomodulation.
Anesth Analg. 1996; 82: 187—204.

56.

Landers DF, Hill GE, Wong KC, et al. Blood transfusion-induced immunomodulation.
Anesth Analg. 1996;82(1):187—204.

57.

Suchner U, Senftleben U. Effekte von mehrfach ungesittigten Fettsauren auf den
Immunstatus: Bedeutung als Strukturund Mediatorbausteine. Infusionsther
Transfusionsmed. 1994;21:59—70.

58.

Suchner U, Senftleben U. Immune modulation by polyunsaturated fatty acids during
nutritional therapy: Interactions with synthesis and effects of eicosanoids. Infusionsther
Transfusionsmed. 1994;21:167—182.

59.

Matera G, Cook JA, Hennigar RA et al. Beneficial effects of a 5-lipoxygenase inhibitor
in endotoxic shock in the rat. J Pharmacol Exp Ther. 1988;247:363—371.

60.

Cook JA, Wise WC, Halushka PV. Protective effect of a selective leukotriene antagonist
in endotoxemia in the rat. J Pharmacol Exp Ther. 1985;235:470—474.

61.

Okada M, Kodama T, Tominaga A, et al. Cytotoxicity of activated platelets to autologous
red blood cells. Br J Haematol. 1992;82:142—150.

62.

Sieunarine K, Langton S, Lawrence-Brown MMD, et al. Elastase levels in salvaged blood
and the effect of cell washing. Aust N Z J Surg. 1990 Aug;60(8):613-6. doi:
10.1111/j.1445-2197.1990.tb07441.x.

25

63.

Martinez‐Sogues L, Blois SL, Manzanilla EG, et al. Exploration of risk factors for non‐
survival and for transfusion‐associated complications in cats receiving red cell
transfusions: 450 cases (2009 to 2017). J Small Anim Pract. 2020;61(3):177-184.
doi:10.1111/jsap.13108

64.

Addonizio VP, Smith JB, Guiod LR, et al. Thromboxane synthesis and platelet protein
release during simulated extracorporeal circulation. Blood. 1979;54:371—376. PMID:
454844.

65.

Relevy H, Koshkaryev A, Manny N, et al. Blood banking-induced alteration of red blood
cell flow properties. Transfusion. 2008 Jan;48(1):136-46. doi: 10.1111/j.15372995.2007.01491.x.

66.

Herring J, Smith S, McMichael M, et al. Microparticles in stored canine erythrocyte
concentrates. Vet Clin Path. 2013 Jun;42(2):163-9. doi: 10.1111/vcp.12034.

67.

Hess JR. An update on solutions for red cell storage. Vox Sang. 2006 Jul;91(1):13-9. doi:
10.1111/j.1423-0410.2006.00778.x.

68.

Rubin O, Delobel J, Prudent M, et al. Red blood cell-derived microparticles isolated from
blood units initiate and propagate thrombin generation. Transfusion. 2013
Aug;53(8):1744-54. doi: 10.1111/trf.12008.

69.

Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles
promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb
Haemost. 2003 Dec;1(12):2561-8. doi: 10.1046/j.1538-7836.2003.00456.x.

70.

Jy W, Ricci M, Shariatmadar S, et al. Microparticles in stored red blood cells as potential
mediators of transfusion complications. Transfusion. 2011; 51(4): 886–893.
doi:10.1111/j.1537-2995.2011.03099.x

71.

McEntire MC, Wardrop KJ, Davis WC. Comparison of established and novel methods
for the detection and enumeration of microparticles in canine stored erythrocyte
concentrates for transfusion. Vet Clin Pathol. 2017;46(1):54-63. doi:10.1111/vcp.12434

72.

Barger AM. Erythrocyte morphology. In: Weiss DJ, Wardrop KJ, eds. Schalm's
Veterinary Hematology. 6th ed. Hoboken, NJ: Wiley- Blackwell, 2010:144-151.

73.

Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell
rheological properties. J Surg Res. 2002 Jan;102(1):6-12. doi: 10.1006/jsre.2001.6306.

74.

Tousoulis D, Kampoli AM, Tentolouris C, et al. The role of nitric oxide on endothelial
function. Curr Vasc Pharmacol. 2012 Jan;10(1):4-18. doi:
10.2174/157016112798829760.

26

75.

Solomon SB, Cortés-Puch I, Sun J, et al. Transfused older stored red blood cells improve
the clinical course and outcome in a canine lethal hemorrhage/reperfusion model.
Transfusion. 2015;55(11):2552-2563. doi:10.1016/j.physbeh.2017.03.040

76.

Shanwell A, Kristiansson M, Remberger M, et al. Generation of cytokines in red cell
concentrates during storage is prevented by prestorage white cell reduction. Transfusion.
1997;37(7):678-684. doi:10.1046/j.1537-2995.1997.37797369441.x

77.

Waddell LS, Holt DE, Hughes D, et al. The effect of storage on ammonia concentration
in canine packed red blood cells. J Vet Emerg Crit Care. 2001;11(1):23-26.
doi:10.1111/j.1476-4431.2001.tb00059.x

78.

Maglaras CH, Koenig A, Bedard DL, et al. Retrospective evaluation of the effect of red
blood cell product age on occurrence of acute transfusion-related complications in dogs:
210 cases (2010-2012). J Vet Emerg Crit Care. 2017;27(1):108-120.
doi:10.1111/vec.12530

79.

Holowaychuk MK, Leader JL, Monteith G. Risk factors for transfusion-associated
complications and nonsurvival in dogs receiving packed red blood cell transfusions: 211
cases (2008–2011). J Am Vet Med Assoc. 2014;244(4):431-437.
doi:10.2460/javma.244.4.431

80.

Kawase H, Egi M, Kanazawa T, et al. Storage duration of transfused red blood cells is
not significantly associated with postoperative adverse events in pediatric cardiac surgery
patients. Transfus Apher Sci. 2016;54(1):111-116. doi:10.1016/j.transci.2016.01.027

81.

Kim-Shapiro DB, Lee J, Gladwin MT. Storage lesion: role of red blood cell breakdown.
Transfusion. 2011;51(4):844-851. doi:10.1111/j.1537-2995.2011.03100.x

82.

Remy KE, Spinella PC. Red blood cell storage age – what we know from clinical trials.
Expert Rev Hematol. 2016;9(11):1011-1013. doi:10.1080/17474086.2016.1243051

83.

Grimshaw K, Sahler J, Spinelli SL, et al. New frontiers in transfusion biology:
identification and significance of mediators of morbidity and mortality in stored red
blood cell concentrated. Transfusion. 2011;51(4):874-880. doi:10.1111/j.15372995.2011.03095.x

84.

Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk
factor for postinjury multiple organ failure. Am J Surg. 1999;178(6):570-572.
doi:10.1016/S0002-9610(99)00239-1

85.

Solomon SB, Wang D, Sun J, et al. Mortality increases after massive exchange
transfusion with older stored blood in canines with experimental pneumonia. Blood.
2013;121(9):1663-1672. doi:10.1182/blood-2012-10-462945

86.

Klein HG. The red cell storage lesion(s): of dogs and men. Blood Transfus.
2017;15(2):107-111. doi:10.2450/2017.0306-16
27

87.

Wang D, Cortés-Puch I, Sun J, et al. Transfusion of older stored blood worsens outcomes
in canines depending on the presence and severity of pneumonia. Transfusion.
2014;54(7):1712-1724. doi:10.1111/trf.12607

88.

Wurlod VA, Smith SA, McMichael MA, et al. Iron metabolism following intravenous
transfusion with stored versus fresh autologous erythrocyte concentrate in healthy dogs.
Am J Vet Res. 2015;76(11):996-1004. doi:10.2460/ajvr.76.11.996

89.

Suffredini DA, Xu W, Sun J, et al. Parenteral irons versus transfused red blood cells for
treatment of anemia during canine experimental bacterial pneumonia. Transfusion.
2017;57(10):2338-2347. doi:10.1111/trf.14214

90.

Lacerda LA, Hlavac NRC, Terra SR, et al. Effects of four additive solutions on canine
leukoreduced red cell concentrate quality during storage. Vet Clin Pathol.
2014;43(3):362-370. doi:10.1111/vcp.12163

91.

Cooley-Lock KM, Williams JP, Williams ML, et al. Assessment of erythrocyte damage
and in-line pressure changes associated with simulated transfusion of canine blood
through microaggregate filters. Am J Vet Res. 2019;80(9):852-861.
doi:10.2460/ajvr.80.9.852

92.

McDevitt RI, Ruaux CG, Baltzer WI. Influence of transfusion technique on survival of
autologous red blood cells in the dog. J Vet Emerg Crit Care. 2011;21(3):209-216.
doi:10.1111/j.1476-4431.2011.00634.x

93.

Blaine KP, Cortés‐Puch I, Sun J, et al. Impact of different standard red blood cell storage
temperatures on human and canine RBC hemolysis and chromium survival. Transfusion.
2019;59(1):347-358. doi:10.1111/trf.14997

94.

Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N. Transfusion
immunomodulation — the case for leukoreduced and (perhaps) washed transfusions.
Blood Cells, Mol Dis. 2013;50(1):61-68. doi:10.1016/j.bcmd.2012.08.009

95.

Kim Y, Xia BT, Chang AL, Pritts TA. Role of leukoreduction of packed red blood cell
units in trauma patients: a review. Int J Hematol Res. 2016;2(2):124-129.
doi:10.17554/j.issn.2409-3548.2016.02.31

96.

Yang H, Kim W, Bae J, et al. Effects of irradiation and leukoreduction on downregulation of CXCL-8 and storage lesion in stored canine whole blood. J Vet Sci.
2019;20(1):72-78. doi:10.4142/jvs.2019.20.1.72

97.

Lozano BL, Blois SL, Wood RD, et al. A pilot study evaluating the effects of prestorage
leukoreduction on markers of inflammation in critically ill dogs receiving a blood
transfusion. J Vet Emerg Crit Care. 2019;29(4):385-390. doi:10.1111/vec.12857

28

98.

McMichael MA, Smith SA, Galligan A, Swanson KS, Fan TM. Effect of leukoreduction
on transfusion-induced inflammation in dogs. J Vet Intern Med. 2010;24(5):1131-1137.
doi:10.1111/j.1939-1676.2010.0561.x

99.

Muro SM, Lee JH, Stokes JV, et al. Effects of leukoreduction and storage on erythrocyte
phosphatidylserine expression and eicosanoid concentrations in units of canine packed
red blood cells. J Vet Intern Med. 2017;31(2):410-418. doi:10.1111/jvim.14664

100.

Fallahi L, Ghiliyan R, Hashemi A, et al. Comparing electrolytes in prestorage leukocytereduced packed cell versus unfiltered packed cell. Iran J Pediatr Hematol Oncol.
2013;3(3):86-90. PMID: 24575277

101.

Lucchese L, Ravagnan S, Da Rold G, et al. Survival of Rickettsia conorii in artificially
contaminated whole and leukoreduced canine blood units during the storage period.
Parasit Vectors. 2020;13(1):118. doi:10.1186/s13071-020-3991-9

102.

Callan MB, Patel RT, Rux AH, et al. Transfusion of 28-day-old leucoreduced or nonleucoreduced stored red blood cells induces an inflammatory response in healthy dogs.
Vox Sang. 2013;105(4):319-327. doi:10.1111/vox.12058

103.

Woźniak MJ, Qureshi S, Sullo N, et al. A comparison of red cell rejuvenation versus
mechanical washing for the prevention of transfusion-associated organ injury in swine.
Anesthesiology. 2018;128(2):375-385. doi:10.1097/ALN.0000000000001973

104.

Press SA, Cooper ES, Stull JW. Electrolyte, acid-base, and hemoglobin oxygen affinity
alterations following irradiation and storage of canine packed red blood cells. Vet Clin
Pathol. 2017;46(4):580-588. doi:10.1111/vcp.12539

105.

Une S, Taura Y, Nakama S, et al. Immunosuppression in dogs by pre-transfusions with
ultraviolet (UV)-irradiated whole blood. J Vet Med Sci. 1991; 53 (5): 811—6. doi:
10.1292/jvms.53.811.

106.

Bala AD, Ozcan M. The effects of freezing on long-term storage of canine erythrocytes.
Pol J Vet Sci. 2016; 19(2): 401—6. doi: 10.1515/pjvs-2016-0050.

107.

Contreras TJ, Lindberd JR, Lowrie GB, et al. Liquid and freeze-preservation of dog red
blood cells. Transfusion. 1979; 19(3): 179—92. doi:10.1046/j.15372995.1979.19379204209.x.

108.

Schmidt A, Refaai M, Kirkley S, et al. Proven and potential clinical benefits of washing
red blood cells before transfusion: current perspectives. Int J Clin Transfus Med.
2016;4:79-88. doi:10.2147/IJCTM.S101401

109.

Smith T, Riley W, Fitzgerald D. In vitro comparison of two different methods of cell
washing. Perfusion. 2013;28(1):34-37. doi:10.1177/0267659112458960

29

110.

Valeri CR, Dennis RC, Ragno G, et al. Survival, function, and hemolysis of shed red
blood cells processed as nonwashed blood and washed red blood. Ann Thorac Surg.
2001;72(5):1598-1602. doi:10.1016/S0003-4975(01)03097-1

111.

Proffitt S, Curnow E, Brown C, et al. Comparison of automated and manual methods for
washing red blood cells. Transfusion. 2018;58(9):2208-2216. doi:10.1111/trf.14781

112.

Khanal G, Huynh RA, Torabian K, et al. Towards bedside washing of stored red blood
cells: a prototype of a simple apparatus based on microscale sedimentation in normal
gravity. Vox Sang. 2018;113(1):31-39. doi:10.1111/vox.12605

113.

Zhao Y, Luo G, Luo H, et al. Modify washing solutions in the process of
deglycerolization in ACP 215 and storage at 4°C in 0.9% sodium chloride in 24h.
Transfus Apher Sci. 2010;43(2):163-165. doi:10.1016/j.transci.2010.07.009

114.

Sasaki J, Tirotta C, Lim H, et al. Comparison of stored red blood cell washing techniques
for priming extracorporeal circuits. Perfusion. 2018;33(2):130-135.
doi:10.1177/0267659117730134

115.

Cortés-Puch I, Wang D, Sun J, et al. Washing older blood units before transfusion
reduces plasma iron and improves outcomes in experimental canine pneumonia. Blood.
2014;123(9):1403-1411. doi:10.1182/blood-2013-11-539353

116.

Grabmer C, Holmberg J, Popovsky M, et al. Up to 21-day banked red blood cells
collected by apheresis and stored for 14 days after automated wash at different times of
storage. Vox Sang. 2006;90(1):40-44. doi:10.1111/j.1423-0410.2005.00719.x

117.

Swindell CG, Barker TA, McGuirk SP, et al. Washing of irradiated red blood cells
prevents hyperkalaemia during cardiopulmonary bypass in neonates and infants
undergoing surgery for complex congenital heart disease. Eur J Cardio-Thoracic Surg.
2007;31(4):659-664. doi:10.1016/j.ejcts.2007.01.014

118.

Bansal I, Calhoun BW, Joseph C, Pothiawala M, Baron BW. A comparative study of
reducing the extracellular potassium concentration in red blood cells by washing and by
reduction of additive solution. Transfusion. 2007;47(2):248-250. doi:10.1111/j.15372995.2007.01095.x

119.

Wozniak MJ, Sullo N, Qureshi S, et al. Randomized trial of red cell washing for the
prevention of transfusion-associated organ injury in cardiac surgery. Br J Anaesth.
2017;118(5):689-698. doi:10.1093/bja/aex083

120.

Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific
and clinical challenge. Am J Med. 1996;101(3):299-308. doi:10.1016/S00029343(96)00124-6

30

121.

Cholette JM, Henrichs KF, Alfieris GM, et al. Washing red blood cells and platelets
transfused in cardiac surgery reduces postoperative inflammation and number of
transfusions. Pediatr Crit Care Med. 2012;13(3):290-299.
doi:10.1097/PCC.0b013e31822f173c

122.

Reinhart WH, Piety NZ, Deuel JW, et al. Washing stored red blood cells in an albumin
solution improves their morphologic and hemorheologic properties. Transfusion.
2015;55(8):1872-1881. doi:10.1111/trf.13052

123.

Hofbauer N, Windberger U, Schwendenwein I, et al. Evaluation of canine red blood cell
quality after processing with an automated cell salvage device. J Vet Emerg Crit Care.
2016;26(3):373-383. doi:10.1111/vec.12472

124.

Loh YS, Tan S, Kwok M, et al. Reduction of biological response modifiers in the
supernatant of washed paediatric red blood cells. Vox Sang. 2016;111(4):365-373.
doi:10.1111/vox.12442

125.

Weisbach V, Ringwald J, Zimmermann R, et al. The in vitro quality of washed,
prestorage leucocyte-depleted red blood cell concentrates. Vox Sang. 2004;87(1):19-26.
doi:10.1111/j.1423-0410.2004.00526.x

126.

Cortés-Puch I, Remy KE, Solomon SB, et al. In a canine pneumonia model of exchange
transfusion, altering the age but not the volume of older red blood cells markedly alters
outcome. Transfusion. 2015;55(11):2564-2575. doi:10.1111/trf.13275

127.

Jagodich TA, Holowaychuk MK. Transfusion practice in dogs and cats: an internet-based
survey. J Vet Emerg Crit Care. 2016;26(3):360-372. doi:10.1111/vec.12451

31

CHAPTER II
EFFECTS OF WASHING UNITS OF CANINE RED BLOOD CELLS ON STORAGE
LESIONS
This chapter is intended for publication as an article in Journal of Veterinary Internal
Medicine. Coll A, Ross M, Williams M, et al. Effects of washing units of canine stored red blood
cells on storage lesions. JVIM (intended submission Spring of 2021).
Introduction
Stored blood products like whole blood and packed red blood cells (pRBC) are
commonly used in veterinary medicine. Both storage duration and environment can have a
substantial impact on red blood cell (RBC) fragility, leading to both in vitro (pre-transfusion) and
in vivo (post-transfusion) hemolysis. The changes that occur within units of stored blood, known
as storage lesions, can create biochemical, biomechanical, and immunologic events that lead to
in vitro and in vivo hemolysis1. Prolonged storage can cause oxidation of proteins and lipids, and
changes in RBC shape, and decrease the circulating survival time of RBCs post-transfusion. In
humans, the accumulation of vasoactive and pro-inflammatory molecules, including cytokines
and arachidonic acid (AA)-derived eicosanoids, and increased RBC fragility2-4 can potentially
increase the risk of transfusion reactions5.
Several methods have been used to reduce the accumulation of storage lesions, improve
erythrocyte health, prolong RBC survival in the recipient, and reduce the risk and severity of
transfusion reactions. Pre-storage leukoreduction and platelet depletion decrease many
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inflammatory mediators and storage lesions in both humans and dogs2,6-13. However, pre-storage
leukoreduction and platelet depletion causes an immediate increase in concentrations of TXB2
and doesn’t eliminate the accumulation of 6-keto-PGF2αin units of canine whole blood8.
Irradiation of stored canine pRBCs has been used to inactivate lymphocytes, but this process had
minimal impact on storage lesion development14. Advancements in cell preservative solutions
have improved erythrocyte health and prolonged storage durations but have not eliminated
storage lesions15.
The use of a pre-transfusion washing technique can remove up to 95% of the
plasma/supernatant within the unit, including proteins, electrolytes, cytokines, microparticles,
antibodies, cellular debris, and other storage lesions10,16-18. In humans, the use of washed blood
products prior to transfusion reduces transfusion reactions, risk of transfusion-associated lung
injury, and hyperkalemia in infant transfusion19-22. Although washing of blood products would be
expected to reduce the accumulation of storage lesions and risk of transfusion reactions, the act
of washing could cause some unintended consequences, including increased RBC fragility and
hemolysis10,16,17,23.
There are multiple techniques that can be used to wash blood products, including use of
an automated closed system, centrifugation techniques, or mechanical washing with an open
system. These techniques use saline or other isotonic/preservative fluids to eliminate storage
lesions while maintaining RBC health16. Automated closed systems can be expensive, and are
not readily available in veterinary hospitals. Therefore, if washing of blood products is going to
be utilized in veterinary clinics, manual techniques would probably be the most commonly used
method. In veterinary medicine, the most effective manual washing technique, which eliminates
storage lesions and perseveres red blood cell health, is unknown.
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The objective of this study was to determine if a manual method of washing can
effectively reduce storage lesions that have accumulated in units of stored canine whole blood
without causing adverse effects to erythrocytes. Our hypotheses were that washing of poststorage units of canine whole blood 1.) would decrease measurable storage lesions prior to a
simulated transfusion, with no subsequent increase in lesions over the duration of a simulated
transfusion, 2.) would cause minimal erythrocyte damage, evaluated by hemolysis, morphology,
and function, and 3.) could be performed in a sterile fashion.

Materials and Methods
Animals
Eight healthy adult research dogs, 5 intact females and 3 castrated males, were used in
this study. The mean age of the dogs was 5.1 years (range, 3.5-6 years) and the mean weight was
27.2 kg (range, 24.6-36.1 kg). The dogs were deemed healthy based on no abnormalities on
physical examination, CBC (including manual platelet count), serum biochemistry, urinalysis,
and heartworm and tick-borne disease testing. The dogs were not exposed to any medications or
vaccines for at least 2 weeks prior to the initiation of the study. A sample size calculation was
performed using results from previous studies10,20,24 performed in humans. The calculation was
performed based on levels of lactate, potassium, and glucose in pre- and post-washed blood
products. Based on these results, 8 dogs were calculated to be needed to have 80% power to find
a 25% reduction in storage lesions with an alpha of 0.05. Animal use was approved by the
Mississippi State University College of Veterinary Medicine Institutional Animal Care and Use
Committee and was in compliance with the requirements of the American Association of
Accreditation of Laboratory Animal Care.
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Donation and washing technique
Each dog underwent standard blood donation. Briefly, the donors were sedated with
acepromazine1 (0.02mg/kg IV) and butorphanol2 (0.1mg/kg IV) and positioned in either right or
left lateral recumbency. The hair overlaying the right jugular vein was clipped and the skin was
aseptically cleaned. A 16-gauge needle was inserted into the jugular vein and, under negative
pressure, approximately 450 ml of blood was collected directly into a standard blood banking
bag containing citrate phosphate dextrose adenine solution (Teruflex blood bag system, Terumo,
Tokyo, Japan). The collection tubing was then stripped to allow for adequate mixing of collected
blood with storage bag preservative and then blood was allowed to fill the line again so that a
whole blood sample could then be obtained from the connecting tubing prior to storage (Prestorage). There were no adverse events detected in the dogs during or after blood collection. All
units were stored vertically at 4°C in a dedicated refrigerator. After 28 days of storage, the units
were removed from refrigeration and gently rocked for 1 minute. A sterile blood spike was
inserted into the unit and a blood sample was collected (Post-storage).
Each unit was manually washed using a protocol previously used in human medicine23.
Briefly, following collection of the post-storage sample, each unit was centrifuged for 10
minutes at 5oC and 4000×g. A syringe was attached to the blood spike, and the plasma was
removed and discarded. The unit was resuspended with 250 ml of cold 0.9% sterile NaCl
(Baxter, Copperfield, IL, USA), gently rocked for 1 minute, and a blood sample was collected
(Wash 1). This centrifugation process was repeated until a total of 3 washes were performed.

1
2

Aceprojet, acepromazine maleate injection, USP (10mg/ml) (Henry Schein Inc.; Dublin, OH, USA)
Torbugesic-SA® IV, butorphanol tartrate injection (10mg/ml) (Zoetis; Kalamazoo, MI, USA)
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Samples were collected at the completion of each wash step (Wash 2 and Wash 3). After the third
wash, the units were centrifuged, the wash saline was removed and 100ml of cold sterile saline
was added to the units. To simulate a transfusion of pRBCs, the units remained at room
temperature (25°C) for 5 hours. Following the simulated transfusion, the units were gently
rocked for 1 minute and a final sample was collected (Post-transfusion).

Blood gas analysis
Blood gas analysis (Stat Profile Prime Plus Critical Care Analyzer, NOVA biomedical,
Waltham, MA) was performed within 30 minutes of sample collection, except for one posttransfusion sample that was analyzed 7 hours after collection due to instrument malfunction. If
the blood gas analyzer was unavailable, a blood lactate (Lactate Plus, NOVA Biomedical,
Waltham, MA) and blood glucose (AlphTrak-2 glucometer, Zoetis, Kalamazoo, MI) were
preformed separately. The blood gas analyzer included the following parameters: pH, pCO2,
pO2, sO2, Na, K, Cl, iCa, iMg, glucose, lactate, methemoglobin (MetHgb), total bilirubin (Tbili),
cell free hemoglobin (HgbF), and TCO2.

Erythrocyte osmotic fragility
Erythrocyte osmotic fragility was completed within 6 hours of sample collection using a
previously described dilution technique25-26. Briefly, a phosphate-buffered 10% NaCl stock
solution was prepared and diluted with distilled water to create a 1% NaCl working solution. For
each blood sample, serial dilutions of the working solution (5 ml) were added to 16 tubes to
create final concentrations of 0.0% to 0.85% NaCl (increments of 0.05% NaCl). From each
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sample, 20 μL was added to each tube, gently mixed, and remained undisturbed at room
temperature for 30 minutes. Samples were centrifuged at 2,000×g for 10 minutes, and the optical
density of the supernatant was measured in triplicate at a wavelength of 540 nm by use of a plate
reader (SpectraMax M5 multimode microplate reader, Molecular Devices LLC, Sunnyvale,
Calif.). The percent hemolysis was calculated by dividing the optical density of the blood
samples at each NaCl concentration by the optical density of the blood sample at 0.0% NaCl.
The mean corpuscular fragility (MCF) was calculated to determine which NaCl concentration
was associated with 50% hemolysis.

CBC & erythrocyte morphology
A CBC was performed within 4 hours of collection using an automated hematology
analyzer (Cell-dyn 3700, Abbott Laboratories, Taguig City, Philippines). The analyzer provided
the following parameters: RBC count, WBC count, platelet count, hematocrit (Hct), mean
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular
hemoglobin concentration (MCHC), red blood cell distribution width (RDW), and hemoglobin
(Hgb).
Erythrocyte morphology was evaluated by a blinded board-certified veterinary clinical
pathologist (MLW). For each blood sample, a blood film was prepared with a standard Wright’s
stain and 10 high-power fields (hpf; 1,000× oil magnification) were evaluated. Microscopic
fields were scanned for abnormal RBCs (eg, echinocytes, keratocytes, acanthocytes,
schistocytes, and target cells) and the frequency of abnormal cells was scored using a subjective
scale as rare (1 to 10 abnormal cells/hpf), few (11 to 50 abnormal cells/hpf), moderate (51 to 100
abnormal cells/hpf), and many (> 100 abnormal cells/hpf).
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Aerobic and anaerobic bacterial culture
Using blood-agar plates, aerobic and anaerobic cultures were performed on the Poststorage and Post-transfusion samples. Samples were considered aseptic if no bacterial growth
was detected after 48 hours of observation. If bacterial growth was detected, further
identification was performed to determine the species of the isolated bacterial colony.

Eicosanoid analysis
Following collection, blood samples were centrifuged at 1800×g for 8 minutes at 25°C,
and the supernatant was frozen in liquid nitrogen and stored at -80°C for later analysis. Using a
previously established liquid-chromatography mass spectrometry technique8,27, with
modifications to the sample workup procedure described below, the concentrations of AA,
prostaglandin F2a (PGF2α), prostaglandin E2 (PGE2), prostaglandin D2 (PGD2), thromboxane B2
(TXB2, a stable metabolite of thromboxane A2), 6-keto-PGF1α (a stable, hydrolyzed product of
prostacyclin), hydroxyeicosatetraenoic acid (HETE), and hydroxyoctadecadienoic acid (HODE)
were measured.
For analysis, deuterated internal standards were added to the thawed plasma samples in
two volumes of ice-cold 1:1 (v/v) methanol/acetonitrile followed by vortex mixing. After
chilling at -20°C for 30 min, the samples were centrifuged at 16,100xg for 10 min at 4°C to
remove precipitated protein and the organic solvents in the supernatants removed in a speed vac
centrifuge. The eicosanoids in the concentrated samples were extracted by using a C18 SepPak
column (HyperSep Retain PEP 60 mg, 1 mL, Thermo Fisher Scientific, Waltham, MA) and
eluted in methanol. The samples were dried under nitrogen gas, resolubilized in 100 µL of
methanol, and 10 µL injected onto a Waters C18 column (1.7 µm particle size, 100mm x 2.1 mm
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internal diameter) (Acquity UPLC BEH C18 column, Waters Corporation, Milford, MA). The
analytes were eluted with a gradient program and introduced into a mass spectrometer (TSQ
Quantum Access Max, Thermo Fisher Scientific Inc). The concentration of each eicosanoid was
determined by measuring the area under each chromatographic peak and comparing this result to
the area under the chromatographic peak for the internal standard. The eicosanoid concentrations
were normalized to the volume of plasma used for analysis and expressed as pmol/mL plasma.
The estimated limits of detection were between 0.1 and 10 nM.

Statistical Analysis
Descriptive and inferential statistics were performed using commercially available
statistic software (SAS for Windows v. 9.4, SAS Institute, Inc. Cary, NC). Impact of stored
blood washing on outcomes of blood gas values, CBC values, and eicosanoid concentrations was
initially assessed using a generalized linear mixed model using PROC MIXED, however models
did not meet the assumptions of homoscedasticity and normality of the residuals. Consequently,
a method similar to the non-parametric Friedman’s test was used. Outcomes were first ranked by
dog using PROC RANK, then analyzed by linear models using PROC MIXED. Dog identity and
sample were included as fixed effects in each model. The LSMESTIMATE statement was used
to compare the following samples in the washing protocol using a simulated adjustment method
for multiple comparisons: Pre-storage vs. Post-storage, Pre-storage vs. Wash 1; Pre-storage vs.
Wash 2; Pre-storage vs. Wash 3; Post-storage vs. Wash 1; Post-storage vs. Wash 2; Post-storage
vs. Wash 3; Post-storage vs. Post-transfusion; Wash 1 vs. Wash 2; Wash 1 vs. Wash 3; Wash 2
vs. Wash 3; Wash 3 vs. Post-transfusion. The simulate option in LSMESTIMATE statement was
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used to adjust p-values for multiple comparisons among sample times. An alpha level of 0.05
was used to determine statistical significance.

Results
Blood gas analysis
Due to malfunctions with the analyzer, post-storage, Wash 1, Wash 2, Wash 3, and posttransfusion samples were not able to be completely evaluated in one unit of blood and data for
these samples only consisted of blood glucose and lactate measurements for all but the prestorage sample.
The results for glucose, lactate, potassium, sodium, iCa, and iMg are represented in
Figure 2.1 and the remaining blood gas results are listed in Table 2.1. There was a significant
(p<0.0001) increase in lactate after storage, but the lactate decreased following each wash (Wash
1, p=0.0016; Wash 2, p=0.0016; Wash 3, p<0.0001), but increased significantly (p=0.0003)
during the simulated transfusion. There was a significant decrease in glucose concentration
(p<0.0001) during storage and after each wash (Wash 1, p<0.0001; Wash 2, p<0.0001; Wash 3,
p<0.0006). There was no change (p=0.9876) in glucose concentration following the simulated
transfusion.
The potassium concentration increased (p=0.0075) during storage, but decreased
significantly (Wash 1, p<0.0001; Wash 2, p=0.0006; Wash 3, p=0.0006) following each wash.
There was no change (p=0.6917) in potassium concentration following the simulated transfusion.
The sodium concentration increased (p=0.0159) during storage, but decreased significantly
(Wash 1, p<0.0001; Wash 2, p<0.0001; Wash 3, p<0.0001) following each wash. There was no
difference (p=0.1063) in sodium concentration between the Pre-storage and Wash 1 samples.
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The chloride concentration increased following each wash (Wash 1, p<0.0002; Wash 2,
p<0.0001; Wash 3, p<0.0001). There was no change in the ionized calcium (p=1.000) and
ionized magnesium (p=1.000) during storage, but there was a progressive increase in both
parameters following each wash and simulated transfusion.
CBC & erythrocyte morphology
The CBC results are summarized in Table 2.2. There were no statistically significant
changes in red blood cell parameters between Pre- and Post-storage samples. There was a
significant increase in RBC count (p=0.0017), hematocrit (p=0.0006), hemoglobin concentration
(p=0.0023), and RDW (p=0.044) between Wash 3 and the simulated transfusion. The hematocrit
also increased, compared to Pre-storage, following Wash 1 (p=0.0011) and Wash 2 (p=0.0328).
The MCV, MCHC, and RDW results are presented in Figure 2.2. Compared to Pre- and
Post-storage samples, there was a significant increase in MCV after each wash, but there no
differences between each wash. The MCV was significantly (P< .0001) greater following the
simulated transfusion compared to Post-storage samples. Compared to Pre- and Post-storage
samples, there was a significant decrease in MCHC after each wash, but not between individual
washes. Compared to Post-storage samples, there was a significant (P< .0001) decrease in the
MCHC after the simulated transfusion. Compared to Pre-storage values, the RDW increased
after each wash (Wash 1, p=0.0009; Wash 2, p<0.0001; Wash 3, p=0.0002), but not between
each wash. When compared to Post-storage values, there was no change in RDW following
Wash 1 (p=0.135), but there was an increase following Wash 2 (p=0.0093), Wash 3 (p=0.0128),
and the simulated transfusion (p<0.0001).
Compared to Pre- and Post-storage samples, there was a significant decrease in WBC
count following all three washes. There was a progressive decrease (p=0.035) in WBC count
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between the first 2 washes, but there was no difference (p=0.927) between Wash 2 and 3. There
was a significant (p<0.0001) increase between Wash 3 and the simulated transfusion.
Compared to Pre-storage samples, there was a significant (p<0.0001) decrease in platelets
after storage and each wash (Wash 1, p<0.0001; Wash 2, p<0.0001; Wash 3, p=0.0003).
However, when compared to Post-storage samples, there was no difference in platelet count
following each wash, but there was a significant (p=0.0006) increase between Wash 3 and the
simulated transfusion.
The erythrocyte morphology results are presented in Table 2.3.

Erythrocyte osmotic fragility
The MCF results are summarized in Table 2.2. The was a significant (p=0.0369) decrease
in the MCF between Pre-storage and Post-storage. Compared to the Post-storage sample, there
was a significant increase in MCF following Wash 1 (p=0.0003), Wash 2 (p=0.0012), and Wash
3 (p<0.0001).

Eicosanoid analysis
The eicosanoid results are summarized in Table 2.4. AA concentrations significantly
(p=0.0006) increased during storage, but compared to Pre- and Post-storage samples, arachidonic
acid concentrations progressively decreased following each wash. Additionally, compared to
Post-storage samples, the AA concentration had significantly (p<0.0001) decreased following the
simulated transfusion. Compared to Pre-storage, the TXB2 concentrations decreased significantly
(p=0.0417) after the first wash, but no other subsequent washes. Compared to Post-storage
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samples, the TXB2 concentrations increased (p=0.0337) after the simulated transfusion. There
were no changes in HODE concentrations during storage. Compared to Post-storage levels, there
was a decreased in HODE concentration after the third wash and simulated transfusion
(p=0.0136 and p=0.0002, respectively). HETE concentrations increased significantly (p=0.0003)
during storage and did not decrease to below Pre-storage levels until Wash 3 (p=0.0178).

Aerobic and anaerobic cultures
For the Post-storage samples, three units had a faint growth of a Bacillus sp. on
enrichment broth. There was no aerobic bacterial growth identified on the Post-transfusion
samples. Anaerobic bacterial growth was not detected in any sample.

Discussion
The manual washing technique used in our study reduced several plasma storage lesions
that had developed in units of stored canine whole blood. However, three sequential washes
adversely affected erythrocyte health by causing an increase in erythrocyte fragility, RDW,
MCV, hemoglobin concentration, and changes in erythrocyte morphology. Fortunately, most of
the measured plasma storage lesions decreased to below pre-storage levels following a single
wash, suggesting that only one wash would be needed to effectively remove most of the storage
lesions that had accumulated in stored units of blood.
Similar to previous studies, our study demonstrated an increase in lactate and pCO2
concentrations during storage14,28-30. During storage, erythrocyte metabolic function continues,
but in an anaerobic environment, requiring the conversion of intra-cellular pyruvate to lactic
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acid31. As previously demonstrated, in both canine and human blood products, lactate begins to
increase within 7 days of storage14,28. The excess lactate promotes the conjugation of bicarbonate
to pCO2 via carbonic anhydrase, and both lactate and pCO2 can contribute to the decrease in the
pH of stored units, which was also demonstrated in our study. Following the first wash, our
study demonstrated a significant decrease in both lactate and pCO2, with the pCO2 falling below
pre-storage levels. However, despite this decrease in lactate and pCO2 levels, the pH inside the
unit continued to decrease, even after 2 additional washes. A potential explanation for the
progressive decrease in pH is continued anaerobic metabolism. During washing and simulated
transfusion, the erythrocytes remain in a low oxygen state and still require anaerobic metabolism.
Although the lactate concentrations in the unit decreased after the first wash, these levels did not
return to pre-storage levels, suggesting continued erythrocyte production of lactate. A second
potential explanation for the progressive decrease in pH is the loss of the buffer, TCO2, during
the washing process. A third potential explanation for the continual decrease in unit pH, is the
wash solution used in our study. The solution used in our washing technique, 0.9% NaCl, has a
pH of 5.0, and it is unknown if the use of a more pH-neutral wash solution would have prevented
the pH of the blood product from continuing to decrease.
Similar to previous studies, our study demonstrated an increase in potassium levels
during storage14,17,20,28,30,31. The increase in potassium could be due to ATP depletion within the
unit, and to the inhibitory effects that low temperatures have on the enzymatic function of Na-KATPase activity33. Makhro et al. demonstrated an increase in RBC sodium uptake and a loss of
intracellular potassium from red cells during storage and shipment33. An increase in plasma
potassium levels during storage has been associated with significant complications, including in
vitro hemolysis during storage28,34,35.
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The transfusion of blood products with increased levels of potassium has not been
associated with clinically significant adverse events28. However, serum potassium concentration
could potentially increase during massive transfusions36, especially in patients that are small and
have concurrent hyperkalemia.
In both human and veterinary medicine, storage of blood products can increase
erythrocyte fragility, causing an increase in in vitro hemolysis and resultant free hemoglobin
concentrations15,29,35,38,39. The transfusion of hemolyzed blood product can lead to lifethreatening acute hemolytic transfusion reactions1. An increase in red cell fragility and hemolysis
can result in the release of cell free hemoglobin, which can contribute to the promotion of
multiple organ failure40, lung injury41-45, nosocomial bacterial infections19, systemic and
pulmonary hypertension41, kidney injury and endothelial dysfunction21. Hemoglobin can
effectively scavenge nitric oxide, causing endothelial dysfunction, vasoconstriction, platelet
aggregation, increased vascular permeability, and leukocyte adhesion46. In the present study,
while there was no change in free hemoglobin during storage, free hemoglobin then increased
after the first, but not subsequent washes, suggesting that washing stored blood products could
increase the risk of in vitro hemolysis. A similar finding was demonstrated with a cell salvage
device that also used 0.9% NaCl to wash canine erythrocytes47. Therefore, careful handling of
these units, including using the least number of washes, would reduce risk of in vitro hemolysis.
Our study also showed an increase in free hemoglobin following the simulated transfusion when
compared to the final wash. One potential explanation for this increase in hemoglobin is
continued decline in RBC health while held at room temperature, instead of refrigeration33.
Cortes-Puch et al evaluated the effects of washing old versus fresh blood prior to
transfusion in a canine pneumonia model and found that washing older blood reduced multiple
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organ injury, lung injury, plasma iron and cell free hemoglobin levels, and improved survival
times42. However, washing of fresh blood caused RBC membrane damage and increased cell free
hemoglobin and iron, and worsened infection and outcomes42. A second study found that even
with different transfused volumes of stored blood, plasma iron and cell free hemoglobin
increased and worsened lung injury and mortality rates. Although washing of blood stored for
14-35 days did result in a separation of Kaplan Meyer curves, the differences in survival in
washed vs non-washed blood stored for that length of time were not statistically different43.
Further studies into the in vitro effects of washing units of stored blood prior to transfusion are
needed in veterinary medicine.
Studies in both human and veterinary medicine have demonstrated that the progressive
depletion of ATP during storage can cause increased senescent signaling through the expression
of the negatively charged cell phospholipid, phosphatidylserine37,48 and degenerative changes to
erythrocyte shape, including echinocytes and spherocytes39,49,50. Our study showed that
echinocytes were detected in 7 dogs in the Pre-storage, Post-storage, and Wash 1 groups, but that
only one dog demonstrated echinocytes following the second wash. This may be the result of
RBC lysis and removal of these fragile cells throughout the washing process. Rouleax and loss of
central pallor were other red cell changes seen with storage. One possible cause for the increase
in rouleaux formation is an increase in beta or gamma globulins, that are produced by activated
leukocytes in the unit. Finally, the loss of central pallor, increased RDW and MCV, and
decreased MCHC with washing supports previous reports of human and canine red blood cell
swelling after manual or automated RBC washing47,51. The cellular swelling during washing is
widely considered to be secondary to build up of osmotically active substances (such as lactate,
chloride, and 2,3-DPG) intracellularly49,52. These osmotically active substances develop in RBCs
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during storage and, after washing, the extracellular osmolality decreases significantly depending
on the washing media used53,54, resulting in an intracellular shift of fluid. Additionally, a storagerelated dysfunction of Na-K-ATPase that may cause an increase concentration of intracellular
sodium may also lead to an osmotic pull of water into the RBC, and cell swelling33,39,47.
Increased MCV due to erythrocyte swelling shortens the lifespan of erythrocytes and increases
osmotic fragility due to the decreased surface area to volume ratio and decreased
deformability47,52. In human, washing with solutions containing dextrose, mannitol, or albumin
that exhibit osmotic or colloidal oncotic effects improve red cell morphology as evidenced by
normalized MCV and increased MCHC, as well as decreased erythrocyte water content and
improved cell health23,24,51,54. Future studies in washing stored canine red cells are needed to
determine optimal washing media to mitigate these changes seen to red cells.
Ionized calcium and ionized magnesium increased following each wash, suggesting that
any residual and unbound CPDA was removed during the washing process. The use of washed
blood products may provide a clinical benefit for patients with a concurrent coagulopathy or
receiving massive transfusions, especially with hepatic dysfunction. Citrate toxicity is an
uncommon but potentially harmful transfusion complication. Any unbound and excess citrate
from the CDPA is usually quickly metabolized and eliminated from the patient. However,
during massive transfusions, especially in patients with hepatic dysfunction, citrate metabolism
can be reduced, causing in vivo calcium chelation and clinical hypocalcemia. Although our study
did not measure citrate concentration in the unit, increases in both calcium and magnesium after
the first wash suggest removal of most citrate. In fact, there was a progressive increase in iCa
and iMg following each wash. With each wash step, it is possible that intracellular, calcium and
magnesium leaked out of the RBCs, which could indicate cellular fragility and damage during
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the washing process. Another possible cause for the increased ionized calcium is platelet
activation; however, citrated storage media has been shown to decreased both platelet and
leukocyte activation and, after prolonged storage, this mechanism is not expected to play a large
role in the change in calcium levels measured in this study55. Finally, approximately 40% of
calcium is bound to albumin. During the washing process, albumin was removed along with the
plasma after the first washing step and so it is possible that the ionized calcium levels seen in this
study were moved into the washing media to maintain calcium homeostasis.
Eicosanoids such as PGF2α, PGE2, PGD2, TXB2, 6-keto-PGF1α, HETEs, and HODEs are
signaling molecules that are derived from AA and are involved in multiple physiologic
processes, such as vascular and bronchial tone, platelet activation, and renal blood flow56.
Elevated levels of eicosanoids have been suggested as a possible cause of TRALI in humans57,
and a reduction in eicosanoids has been proposed as a mechanism to reduce transfusion
reactions3,58. In humans, the use of leukoreduction filters prior to storage can reduce the
accumulation of eicosanoids in stored units5; however, in dogs, leukoreduction causes an
immediate increase in TXB2 and PGF2α, and does not decrease 6-keto-PGF1α8. Our study
demonstrated that manual washing decreased TXB2 and PGE2 levels, following one and two
washes respectively, when compared to pre-storage levels. These results are similar to studies in
units of human blood, which showed that washing caused a 95% reduction of eicosanoids that
accumulated during storage, including TXB2 and PGE23.
HETEs and HODEs are lipoxygenase (LOX) induced oxidative byproducts of AA that
have vasoactive effects. 12-HETE directly contributes to platelet activation and aggregation, and
influences the expression of the platelet adhesion molecule P-selectin59. HODEs are
proinflammatory eicosanoids that contribute to leukocyte migration; specifically, human and
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bovine neutrophil chemotaxis60 and cytotoxic NK cell migration61. Increases in both of these
eicosanoids, and HETEs in particular, have recently been associated with vascular dysfunction,
hypertension, and microalbuminuria in greyhounds62. Our study is the first to demonstrate the
presence of 12-HETE and HODEs in stored canine whole blood; however, the roles that 12HETE and HODEs play in transfusion reactions are unknown, and further studies are needed.
Eicosanoids have the potential to cause profound vascular effects in recipients, such as
vasoconstriction mediated by thromboxane and HETEs62,63. In mice, the accumulation of
HETEs and HODEs during storage is associated with a poor 24-hour RBC recovery in mice
post-transfusion64. Furthermore, AA and HETEs have been implicated as the “second hit” in
TRALI in people57. Other potential clinical consequences of increased exposure to eicosanoids
include immunomodulation65, enhancement of the systemic inflammatory response syndrome
(SIRS)66-69, and leukocyte and platelet activation59,70,71. Further investigation into the effects of
eicosanoids and their physiologic effects and clinical significance in transfusion recipients is
needed.
The present study had several limitations. Firstly, there were numerous technical
problems with the blood gas analyzer that caused absent or partial data for several analytes.
Secondly, one blood unit ruptured during the final centrifugation, which prevented the collection
of the post-transfusion samples. Thirdly, our study only evaluated one type of wash media, 0.9%
NaCl, and the use of different wash solutions, such as solutions that are buffered and
physiologically similar to plasma, could have caused less cellular damage and potentially
reduced the amount of hemolysis24,72. We chose 0.9% saline as the wash solution for use in this
study because it has previously been used in humans to reduce storage lesions, and is readily
available in most veterinary clinics10,23,24. Similarly, this study only used one washing protocol,
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centrifugation speed and time, and other protocols have been reported in human transfusion
medicine10,23,24. In dogs, additional studies are needed to evaluate which wash solution and
centrifugation protocol best eliminates storage lesions and maintains cell health.
The present study demonstrates the manual washing of units of canine whole blood
significantly reduced most storage lesions within the units, with many lesions attaining well
below pre-storage levels. Based on the results of this study, we suspect that a single wash is all
that is required to eliminate most storage lesions. Further investigation into alternative washing
solutions and protocols may enable greater reductions in plasma storage lesions with minimal
effects on erythrocyte health.
Table 2.1

Blood gas analysis
Pre-storage*

Post-storage

Wash 1†

Wash 2‡

Wash 3

Transfusion*†‡

pH

6.91 ± 0.16

6.63 ± 0.04a

6.59 ± 0.08a

6.44 ± 0.31b

6.20 ± 0.43bc

5.88 ± 0.31c

pCO2 (mmHg)

53.1 ± 12

100.7 ± 16.1

35.8 ± 6.7

14.5 ± 6.8

4.7 ± 3.4a

3.2 ± 4.1a

pO2 (mmHg)

89 ± 10a

95.7 ± 36a

107.4 ± 45.6ab

105.8 ± 34.8b

106.3 ± 28.1bc

112.4 ± 42.3c

sO2 (%)

91.3 ± 5.5a

84.1 ± 7.5b

87.9 ± 6.3ab

88 ± 5.9ab

89.3 ± 5.3ac

89.7 ± 5.3bc

TCO2 (mmol/L)

12.4 ± 2.2a

13.8 ± 1.7a

3.7 ± 1.5

2.5 ± 0b

2.5 ± 0bc

2.5 ± 0c

MetHb (%)

0.6 ± 0.2a

1 ± 0.4a

1.9 ± 0.4b

1.8 ± 0.4b

2 ± 0.4b

1.5 ± 0.3

Tbili (mg/dL)

1.8 ± 0.4a

2.5 ± 1.8ab

3.1 ± 2.1c

3.1 ± 1.8c

3.2 ± 2c

1 ± 0.6b

Blood gas analysis results (mean ± standard deviation) from 8 units of canine whole blood at
donation (Pre-storage), storage (Post-storage), three washes with 0.9% NaCl (Wash 1, Wash 2,
Wash 3), and after a simulated transfusion (Transfusion).
Comparison was not performed between samples that share the same symbols *, ꝉ, and ⱡ. Results
that do not share a letter differed significantly (P <.05) on posthoc analysis.
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Table 2.2

CBC results
Pre-storage*

Post-storage

Wash 1†

Wash 2‡

Wash 3

Transfusion*†‡

WBC 10^3/ul

4.43 ±1.25a

4.69 ±1.35abc

3.86 ±1.41

3.4 ±1.46d

3.22 ±1.47bd

5.22 ±1.55 c

RBC 10^6/ul

5.06 ±0.82a

5.47 ±0.82ab

5.36 ±0.82a

5.17 ±0.82a

5.04 ±0.82a

7.01 ±0.87b

HGB g/dl

12.51 ±2.00a

13.28 ±1.99abc

13.25±2.00b

12.76 ±1.99ab

12.58 ±2.00ab

17.54 ±2.14c

HCT %

34.61 ±6.64a

37.76 ±6.64ab

39.83 ±6.62b

38.43 ±6.61b

37.46 ±6.61ab

53.4 ±7.10

MCV fL

68.5 ±4.51a

69.08 ±4.37a

74.45 ±4.22 b

74.54 ±4.19b

74.58 ±4.15bc

76.41 ±4.13c

MCH pg

24.78 ±0.88ab

24.28 ±0.72a

24.79 ±0.69ac

24.78 ±0.73ac

25.03 ±0.75 bcd

24.99 ±0.75d

MCHC g/dl

36.18 ±1.92a

35.15 ±1.91a

33.35 ±1.89b

33.3 ±1.89b

33.61 ±1.90bc

32.74 ±1.90c

RDW

14.64 ±1.14a

15.28 ±1.13ab

15.85 ±1.13bc

16.03 ±1.14c

15.95 ±1.14c

17.1 ±1.19

PLT 10^3/ul

149 ±38.82

91.25 ±38.76 ab

73.63 ±39.28 a

81.63 ±39.15 ac

84.75 ±39.11 bc

146 ±39.62

MCF (%)

0.487 ±0.091a

0.430 ±0.091b

0.504 ±0.084ac

0.490 ±0.083acd

0.575 ±0.080cde

0.569 ±0.080e

Mean ± deviation CBC parameters and MCF results in 8 units of canine whole blood from
healthy donors at the time of donation (Pre-storage), after 28 days of storage at 4°C (Poststorage), after 1 wash with 250ml 0.9%NaCl (Wash 1), after the second wash with 250ml with
0.9%NaCl (Wash 2), after the third wash with 0.9% NaCl (Wash 3), and after reconstitution with
100ml 0.9%NaCl and a simulated transfusion over 5 hours (Transfusion).
Comparison was not performed between samples that share the same symbols *, ꝉ, and ⱡ. Results
that do not share a letter differed significantly (P <.05) on posthoc analysis.
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Table 2.3
Morphology

Erythrocyte morphology results
Pre-storage

Post-storage

Wash 1

Wash 2

Wash 3

Transfusion

7 (rare to moderate)

7 (moderate to many)

7 (moderate to many)

1 (moderate)

ND

ND

Codocytes

1 (rare)

3 (rare)

ND

ND

ND

ND

Keratocytes

5 (rare to mild)

1 (rare)

ND

ND

ND

ND

Eccentrocyte

1 (rare)

ND

ND

ND

ND

ND

Dacrocyte

ND

ND

2 (mild to moderate)

2 (rare to mild)

2 (rare to mild)

2 (rare to mild)

Ovalocyte

ND

ND

1 (mild)

3 (rare to mild)

1 (rare)

2 (rare to mild)

1 (mild)

1 (mild)

ND

ND

ND

ND

Smudge cells

ND

ND

8 (mild to many)

7 (many)

7 (many)

7 (many)

Rouleaux

ND

ND

3

5

7

3

Lack of Central Pallor

ND

ND

5

8

8

7

Cells Not Spread Out

ND

ND

3

3

3

4

Echinocytes

Poikilocytosis
Other Descriptions

Abnormal erythrocyte morphology for samples at the time of unit of canine whole blood
collection (Pre-storage), after 28 days storage at 4°C (Post-storage), after the first (Wash 1),
second (Wash 2), and third (Wash 3) wash with 250ml of cold 0.9% NaCl, and after a 5 hour
simulated transfusion at 25°C (Transfusion).
Results reported are the number of samples for which the RBC and WBC morphology was
present. Frequency of abnormalities was scored by use of a subjective scale as rare (1-10
abnormal cells/hpf), mild (11-50 abnormal cells/hpf), moderate (51-100 abnormal cells/hpf), and
many (>100 abnormal cells/hpf). ND= not detected.
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Table 2.4

Eicosanoid results
Pre-storage*

Post-storage

Wash 1†

Wash 2‡

Wash 3

Transfusion*†‡

AA (pmol/ml)

56.0 ±42.2

96.8 ±41.5

18.3 ±40.0

3.7 ±40.1

0.9 ±40.2

0.3 ±40.2

PGF2α (pmol/ml)

2.4 ±2.8

2.1 ±2.8

2.0 ±2.7

2.3 ±2.7

1.7 ±2.7

1.7 ±2.6

TXB2 (pmol/ml)

7.2 ±49.6 a

6.7 ±49.6 ab

4.6 ±49.6 b

7.1 ±49.6 ab

9.0 ±49.6 abc

73.5 ±49.6 c

PGE2 (pmol/ml)

0.4 ±0.3 a

0.2 ±0.3 abc

0 ±0.3 ab

0 ±0.3 b

0.1 ±0.3 abc

0 ±0.3 c

PGD2 (pmol/ml)

0.082 ±0.1

0.059 ±0.1

0.004 ±0.1

0.004 ±0.1

0.069 ±0.1

0.009 ±0.1

6-keto-PGF1α (pmol/ml)

0.004 ±0

0.005 ±0

0.005 ±0

0.000 ±0

0.001 ±0

0.008 ±0

12-HETE (pmol/ml)

34.5 ±63.7 a

129.4 ±65.5 b

106.9 ±68.9 ab

42.1 ±68.7 a

12.0 ±68.8 c

5.1 ±69.0 c

HODE (pmol/ml)

8.5 ±10.4 ac

11.1 ±10.4 ab

8.0 ±10.2 ac

12.7 ±10.1 ac

4.8 ±5.4 bc

1.3 ±5.0 b

Mean ± deviation eicosanoid concentrations in 8 units of canine whole blood from healthy
donors at the time of donation (Pre-storage), after 28 days of storage at 4°C (Post-storage), after
1 wash with 250ml 0.9%NaCl (Wash 1), after the second wash with 250ml with 0.9%NaCl
(Wash 2), after the third wash with 0.9% NaCl (Wash 3), and after reconstitution with 100ml
0.9%NaCl and a simulated transfusion over 5 hours (Transfusion).
Comparison was not performed between samples that share the same symbols *, ꝉ, and ⱡ. The
shaded results could not be modeled during statistical analysis and therefore comparisons could
not be performed. Results that do not share a letter differed significantly (P <.05) on posthoc
analysis.
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Figure 2.1

Select blood gas analysis results.

Blood gas analysis results (glucose (A), lactate (B), potassium (C), ionized calcium (D), ionized
magnesium (E), sodium (F)). The box and whiskers plot demonstrate the median (line),
interquartile range (box), and total range (whiskers). Results that do not share a letter differed
significantly (P <.05) on posthoc analysis. Pages 40-41.
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Figure 2.2

Select CBC results

CBC results (MCV (A), MCHC (B), RDW (C)). The box and whiskers plot demonstrate the
median (line), interquartile range (box), and total range (whiskers). Results that do not share a
letter differed significantly (P <.05) on posthoc analysis. Pages 41-42.

55

References
1.

Patterson J, Rousseau A, Kessler RJ, et al. In vitro lysis and acute transfusion reactions
with hemolysis caused by inappropriate storage of canine red blood cell products. J Vet
Intern Med. 2011;25(4):927-933. doi:10.1111/j.1939-1676.2011.0737.x

2.

Shanwell A, Kristiansson M, Remberger M, et al. Generation of cytokines in red cell
concentrates during storage is prevented by prestorage white cell reduction. Transfusion.
1997;37(7):678-684. doi:10.1046/j.1537-2995.1997.37797369441.x

3.

Jacobi K, Walther A, Lörler H, et al. Plasma levels of eicosanoids after transfusion of
intraoperatively salvaged blood. Vox Sang. 2000;78(1):31-36. doi:10.1159/000031146

4.

Fu X, Felcyn JR, Odem-Davis K, et al. Bioactive lipids accumulate in stored red blood
cells despite leukoreduction: a targeted metabolomics study. Transfusion.
2016;56(10):2560-2570. doi:10.1111/trf.13748

5.

Jacobi KE, Wanke C, Jacobi A, et al. Determination of eicosanoid and cytokine
production in salvaged blood, stored red blood cell concentrates, and whole blood. J Clin
Anesth. 2000;12(2):94-99. doi:10.1016/S0952-8180(00)00122-7

6.

Richter JR, Sutton JM, Hexley P, Johannigman TA, Lentsch AB, Pritts TA.
Leukoreduction of packed red blood cells attenuates proinflammatory properties of
storage-derived microvesicles. J Surg Res. 2018;223:128-135.
doi:10.1016/j.jss.2017.09.052

7.

Nagura Y, Tsuno NH, Tanaka M, Matsuhashi M, Takahashi K. The effect of pre-storage
whole-blood leukocyte reduction on cytokines/chemokines levels in autologous CPDA-1
whole blood. Transfus Apher Sci. 2013;49(2):223-230. doi:10.1016/j.transci.2013.01.006

8.

Muro SM, Lee JH, Stokes JV, et al. Effects of leukoreduction and storage on erythrocyte
phosphatidylserine expression and eicosanoid concentrations in units of canine packed
red blood cells. J Vet Intern Med. 2017;31(2):410-418. doi:10.1111/jvim.14664

9.

McMichael MA, Smith SA, Galligan A, Swanson KS, Fan TM. Effect of leukoreduction
on transfusion-induced inflammation in dogs. J Vet Intern Med. 2010;24(5):1131-1137.
doi:10.1111/j.1939-1676.2010.0561.x

10.

Loh YS, Tan S, Kwok M, et al. Reduction of biological response modifiers in the
supernatant of washed paediatric red blood cells. Vox Sang. 2016;111(4):365-373.
doi:10.1111/vox.12442

11.

Lozano BL, Blois SL, Wood RD, et al. A pilot study evaluating the effects of prestorage
leukoreduction on markers of inflammation in critically ill dogs receiving a blood
transfusion. J Vet Emerg Crit Care. 2019;29(4):385-390. doi:10.1111/vec.12857

56

12.

Callan MB, Patel RT, Rux AH, et al. Transfusion of 28-day-old leucoreduced or nonleucoreduced stored red blood cells induces an inflammatory response in healthy dogs.
Vox Sang. 2013;105(4):319-327. doi:10.1111/vox.12058

13.

Yang H, Kim W, Bae J, et al. Effects of irradiation and leukoreduction on downregulation of CXCL-8 and storage lesion in stored canine whole blood. J Vet Sci.
2019;20(1):72-78. doi:10.4142/jvs.2019.20.1.72

14.

Press SA, Cooper ES, Stull JW. Electrolyte, acid-base, and hemoglobin oxygen affinity
alterations following irradiation and storage of canine packed red blood cells. Vet Clin
Pathol. 2017;46(4):580-588. doi:10.1111/vcp.12539

15.

Yoshida T, Prudent M, D’Alessandro A. Red blood cell storage lesion: causes and
potential clinical consequences. Blood Transfus. 2019;17(1):27-52.
doi:10.2450/2019.0217-18

16.

Schmidt A, Refaai M, Kirkley S, et al. Proven and potential clinical benefits of washing
red blood cells before transfusion: current perspectives. Int J Clin Transfus Med.
2016;4:79-88. doi:10.2147/IJCTM.S101401

17.

Grabmer C, Holmberg J, Popovsky M, et al. Up to 21-day banked red blood cells
collected by apheresis and stored for 14 days after automated wash at different times of
storage. Vox Sang. 2006;90(1):40-44. doi:10.1111/j.1423-0410.2005.00719.x

18.

Cholette JM, Henrichs KF, Alfieris GM, et al. Washing red blood cells and platelets
transfused in cardiac surgery reduces postoperative inflammation and number of
transfusions. Pediatr Crit Care Med. 2012;13(3):290-299.
doi:10.1097/PCC.0b013e31822f173c

19.

Cholette JM, Pietropaoli AP, Henrichs KF, et al. Longer RBC storage duration is
associated with increased postoperative infections in pediatric cardiac surgery. Pediatr
Crit Care Med. 2015;16(3):227-235. doi:10.1097/PCC.0000000000000320

20.

Bansal I, Calhoun BW, Joseph C, Pothiawala M, Baron BW. A comparative study of
reducing the extracellular potassium concentration in red blood cells by washing and by
reduction of additive solution. Transfusion. 2007;47(2):248-250. doi:10.1111/j.15372995.2007.01095.x

21.

Woźniak MJ, Qureshi S, Sullo N, et al. A comparison of red cell rejuvenation versus
mechanical washing for the prevention of transfusion-associated organ injury in swine.
Anesthesiology. 2018;128(2):375-385. doi:10.1097/ALN.0000000000001973

22.

Klein HG. The red cell storage lesion(s): of dogs and men. Blood Transfus.
2017;15(2):107-111. doi:10.2450/2017.0306-16

57

23.

Weisbach V, Ringwald J, Zimmermann R, et al. The in vitro quality of washed,
prestorage leucocyte-depleted red blood cell concentrates. Vox Sang. 2004;87(1):19-26.
doi:10.1111/j.1423-0410.2004.00526.x

24.

Proffitt S, Curnow E, Brown C, et al. Comparison of automated and manual methods for
washing red blood cells. Transfusion. 2018;58(9):2208-2216. doi:10.1111/trf.14781

25.

McDevitt RI, Ruaux CG, Baltzer WI. Influence of transfusion technique on survival of
autologous red blood cells in the dog. J Vet Emerg Crit Care. 2011;21(3):209-216.
doi:10.1111/j.1476-4431.2011.00634.x

26.

Cooley-Lock KM, Williams JP, Williams ML, et al. Assessment of erythrocyte damage
and in-line pressure changes associated with simulated transfusion of canine blood
through microaggregate filters. Am J Vet Res. 2019;80(9):852-861.
doi:10.2460/ajvr.80.9.852

27.

Xie S, Borazjani A, Hatfield MJ, Edwards CC, Potter PM, Ross MK. Inactivation of
Lipid Glyceryl Ester Metabolism in Human THP1 Monocytes/Macrophages by Activated
Organophosphorus Insecticides: Role of Carboxylesterases 1 and 2. Chem Res Toxicol.
2010;23(12):1890-1904. doi:10.1021/tx1002194

28.

Rodrigues RR, Kayano CY, dos Santos VP, Moroz LR, Fantoni DT, Ambrósio AM.
Evaluation of hematologic, biochemical, and blood gas variables in stored canine packed
red blood cells, and the impact of storage time on blood recipients. Vet Clin Pathol.
2020;49(2):198-206. doi:10.1111/vcp.12865

29.

Blaine KP, Cortés‐Puch I, Sun J, et al. Impact of different standard red blood cell storage
temperatures on human and canine RBC hemolysis and chromium survival. Transfusion.
2019;59(1):347-358. doi:10.1111/trf.14997

30.

Smith T, Riley W, Fitzgerald D. In vitro comparison of two different methods of cell
washing. Perfusion. 2013;28(1):34-37. doi:10.1177/0267659112458960

31.

Rosenstein PG, Tennent-Brown BS, Huges D. Clinical use of plasma lactate
concentration. Part1: Physiology, pathophysiology, and measurement. J Vet Emerg Crit
Care. 2008;18(2);85-105.

32.

Olson J, Talekar M, Sachdev M, et al. Potassium Changes Associated With Blood
Transfusion in Pediatric Patients. Am J Clin Pathol. 2013;139(6):800-805.
doi:10.1309/AJCP2MP8OIIXNKXF

33.

Makhro A, Huisjes R, Verhagen LP, et al. Red cell properties after different modes of
blood transportation. Front Physiol. 2016;7:288. doi:10.3389/fphys.2016.00288

34.

Price GS, Armstrong J, McLeod DA, et al. Evaluation of citrate-phosphate-dextroseadenine as a storage medium for packed canine erythrocytes. J Vet Intern Med. 1988 JulSep;2(3):126-32. doi: 10.1111/j.1939-1676.1988.tb02808.x.
58

35.

Lacerda LA, Hlavac NRC, Terra SR, et al. Effects of four additive solutions on canine
leukoreduced red cell concentrate quality during storage. Vet Clin Pathol.
2014;43(3):362-370. doi:10.1111/vcp.12163

36.

Jutkowitz LA, Rozanski EA, Moreau JA, Rush JE. Massive transfusion in dogs: 15 cases
(1997-2001). J Am Vet Med Assoc. 2002;220(11):1664-1669.
doi:10.2460/javma.2002.220.1664

37.

Raat NJ, Ince C. Oxygenating the microcirculation: the perspective from blood
transfusion and blood storage. Vox Sang. 2007; 93, 12–18. doi: 10.1111/j.14230410.2007.00909.x

38.

Offner PJ: Age of blood does it make a difference? Crit Care. 2004;8:S24–S26

39.

Obrador R, Musulin S, Hansen B. Red blood cell storage lesion. J Vet Emerg Crit Care.
2015;25(2):187-199. doi:10.1111/vec.12252

40.

Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk
factor for postinjury multiple organ failure. Am J Surg. 1999;178(6):570-572.
doi:10.1016/S0002-9610(99)00239-1

41.

Solomon SB, Wang D, Sun J, et al. Mortality increases after massive exchange
transfusion with older stored blood in canines with experimental pneumonia. Blood.
2013;121(9):1663-1672. doi:10.1182/blood-2012-10-462945

42.

Cortés-Puch I, Wang D, Sun J, et al. Washing older blood units before transfusion
reduces plasma iron and improves outcomes in experimental canine pneumonia. Blood.
2014;123(9):1403-1411. doi:10.1182/blood-2013-11-539353

43.

Cortés-Puch I, Remy KE, Solomon SB, et al. In a canine pneumonia model of exchange
transfusion, altering the age but not the volume of older red blood cells markedly alters
outcome. Transfusion. 2015;55(11):2564-2575. doi:10.1111/trf.13275

44.

Wang D, Cortés-Puch I, Sun J, et al. Transfusion of older stored blood worsens outcomes
in canines depending on the presence and severity of pneumonia. Transfusion.
2014;54(7):1712-1724. doi:10.1111/trf.12607

45.

Suffredini DA, Xu W, Sun J, et al. Parenteral irons versus transfused red blood cells for
treatment of anemia during canine experimental bacterial pneumonia. Transfusion.
2017;57(10):2338-2347. doi:10.1111/trf.14214

46.

Tousoulis D, Kampoli AM, Tentolouris C, et al. The role of nitric oxide on endothelial
function. Curr Vasc Pharmacol. 2012 Jan;10(1):4-18. doi:
10.2174/157016112798829760.

59

47.

Hofbauer N, Windberger U, Schwendenwein I, et al. Evaluation of canine red blood cell
quality after processing with an automated cell salvage device. J Vet Emerg Crit Care.
2016;26(3):373-383. doi:10.1111/vec.12472

48.

Oliver CS, Andrews GA, Smith JE, et al. Erythrocyte Structure and Function. In: Weiss
DJ, Wardrop KJ, eds. Schalm's Veterinary Hematology. 6th ed. Hoboken, NJ: WileyBlackwell, 2010:123-129.

49.

Harvey JW. Erythrocyte biochemistry. In: Weiss DJ, Wardrop KJ, eds. Schalm's
Veterinary Hematology. 6th ed. Hoboken, NJ: Wiley- Blackwell, 2010:131-135.

50.

Kozlova E, Chernysh A, Moroz V, Sergunova V, Gudkova O, Kuzovlev A. Nanodefects
of membranes cause destruction of packed red blood cells during long-term storage. Exp
Cell Res. 2015;337(2):192-201. doi:10.1016/j.yexcr.2015.07.009

51.

Zhao Y, Luo G, Luo H, et al. Modify washing solutions in the process of
deglycerolization in ACP 215 and storage at 4°C in 0.9% sodium chloride in 24h.
Transfus Apher Sci. 2010;43(2):163-165. doi:10.1016/j.transci.2010.07.009

52.

Beutler E. Liquid preservation of red cells, In: Rossi E, Simon T, Moss G, et al. eds.
Principles of Transfusion Medicine. 2nd edn. Baltimore, MD: Williams & Wilkins; 1996,
pp. 51–60.

53.

Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific
and clinical challenge. Am J Med. 1996;101(3):299-308. doi:10.1016/S00029343(96)00124-6

54.

Reinhart WH, Piety NZ, Deuel JW, et al. Washing stored red blood cells in an albumin
solution improves their morphologic and hemorheologic properties. Transfusion.
2015;55(8):1872-1881. doi:10.1111/trf.13052

55.

Gubensek J, Strobl K, Harm S, et al. Influence of citrate concentration on the activation
of blood cells in an in vitro dialysis setup. PLoS One. 2018;13(6):2-13.
doi:10.1371/journal.pone.

56.

Fürstenberger G, Marks F, Krieg P. Arachidonate 8(S)-lipoxygenase. Prostaglandins
Other Lipid Mediat. 2002;68-69:235-243. doi:10.1016/S0090-6980(02)00033-3

57.

Silliman CC, Moore EE, Kelher MR, et al. Identification of lipids that accumulate during
the routine storage of prestorage leukoreduced red blood cells and cause acute lung
injury. Transfusion. 2011;51:2549-54.

58.

Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N. Transfusion
immunomodulation — the case for leukoreduced and (perhaps) washed transfusions.
Blood Cells, Mol Dis. 2013;50(1):61-68. doi:10.1016/j.bcmd.2012.08.009

60

59.

Powell WS, Rokach J. Biosynthesis, biological effects, and receptors of
hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs)
derived from arachidonic acid. Biochim Biophys Acta - Mol Cell Biol Lipids.
2015;1851(4):340-355. doi:10.1016/j.bbalip.2014.10.008

60.

Henricks PAJ, Engels F, van der Vliet H, Nijkamp FP. 9-and 13-hydroxy-linoleic acid
posses chemotactic activity for bovine and human polymorphonuclear leukocytes.
Prostaglandins. 1991;41(1):21-27. doi:10.1016/0090-6980(91)90101-K

61.

Rolin J, Al-Jaderi Z, Maghazachi AA. Oxidized lipids and lysophosphatidylcholine
induce the chemotaxis and intracellular calcium influx in natural killer cells.
Immunobiology. 2013;218(6):875-883. doi:10.1016/j.imbio.2012.10.009

62.

Martinez‐Sogues L, Blois SL, Manzanilla EG, et al. Exploration of risk factors for non‐
survival and for transfusion‐associated complications in cats receiving red cell
transfusions: 450 cases (2009 to 2017). J Small Anim Pract. 2020;61(3):177-184.
doi:10.1111/jsap.13108

63.

Addonizio VP, Smith JB, Guiod LR, et al. Thromboxane synthesis and platelet protein
release during simulated extracorporeal circulation. Blood. 1979;54:371—376. PMID:
454844.

64.

Zimring JC, Smith N, Stowell SR, et al. Strain-specific red blood cell storage,
metabolism, and eicosanoid generation in a mouse model. Transfusion. 2014;54(1):137148. doi:10.1111/trf.12264

65.

Dennis F, Landers, DF, Gary EH, et al. Blood transfusion-induced immunomodulation.
Anesth Analg. 1996; 82: 187—204.

66.

Suchner U, Senftleben U. Effekte von mehrfach ungesittigten Fettsauren auf den
Immunstatus: Bedeutung als Strukturund Mediatorbausteine. Infusionsther
Transfusionsmed. 1994;21:59—70.

67.

Suchner U, Senftleben U. Immune modulation by polyunsaturated fatty acids during
nutritional therapy: Interactions with synthesis and effects of eicosanoids. Infusionsther
Transfusionsmed. 1994;21:167—182.

68.

Matera G, Cook JA, Hennigar RA et al. Beneficial effects of a 5-lipoxygenase inhibitor
in endotoxic shock in the rat. J Pharmacol Exp Ther. 1988;247:363—371.

69.

Cook JA, Wise WC, Halushka PV. Protective effect of a selective leukotriene antagonist
in endotoxemia in the rat. J Pharmacol Exp Ther. 1985;235:470—474.

70.

Okada M, Kodama T, Tominaga A, et al. Cytotoxicity of activated platelets to autologous
red blood cells. Br J Haematol. 1992;82:142—150.

61

71.

Sieunarine K, Langton S, Lawrence-Brown MMD, et al. Elastase levels in salvaged blood
and the effect of cell washing. Aust N Z J Surg. 1990 Aug;60(8):613-6. doi:
10.1111/j.1445-2197.1990.tb07441.x.

72.

Sasaki J, Tirotta C, Lim H, et al. Comparison of stored red blood cell washing techniques
for priming extracorporeal circuits. Perfusion. 2018;33(2):130-135.
doi:10.1177/0267659117730134

62

CHAPTER III
CONCLUSION
To create a landscape page, you just rotate the page using the “Orientation” option in the
Layout Tab. This will put your page number at the bottom of the page. If you would like to
print a hard copy and have the page number similar to the portrait pages, we can help you make
those changes.
The work provided in this thesis details a manual washing technique, previously used in
human transfusion medicine1, utilized to wash stored canine red blood cells. The technique was
simple to perform with minimal time, skill, and supplies needed. Furthermore, our research
showed that manual washing of storage canine units of red blood cells successfully reduced
concentrations of plasma storage lesions.
As this thesis has demonstrated that washing units of canine red cells can effectively
reduce plasma storage lesions, future studies should focus on improving cell health through
altering the technique. The first washing step appeared to be the most successful in reducing
storage lesion concentration. Therefore, recommendations for future use may likely consist of a
single washing step. As subsequent washes occurred there were some unwanted consequences of
the washing procedure, including red cell swelling. In humans, various washing media have been
explored to try and improve cellular health, with options including PlasmaLyte®, 1 and 5%
albumin products, deglycerolization media, and mannitol-dextrose solutions2-5. While no
extensive studies exist to allow comparison of all washing media available, there were several
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reports that solutions with colloidal components results in less hemolysis compared to others1-3,5,.
Future studies may include incorporating different washing media into the design to determine
the best media to maintain cell health. In addition to washing media, future studies should also
investigate the optimal centrifugation speed and time, as there are several manual techniques
described in human literature with no single effective technique described2,4,6.
Although these studies may show improved cell health through altering the washing
technique, the manual washing technique described here effectively reduced plasma storage
lesions within units of stored canine red blood cells. A washing technique may benefit patients
receiving massive transfusions (>90 ml/kg in 24 hours or >45 ml/kg in 3 hours)7. Dogs receiving
massive transfusions have been well documented to develop citrate toxicity, in which the
excessive amounts of citrated anticoagulant chelate the patient’s calcium in vivo7. The resulting
hypocalcemia can produce significant clinical signs in patients undergoing massive transfusions
and can even be life-threatening7. Taking the short time to wash the units of stored blood prior to
transfusing stored blood to these patients can reduce this risk almost completely based on this
study’s results.
Another patient group that may benefit from the process of washing red cells prior to
transfusion are patients with known severe infections requiring transfusion, when only older
(>14 days of storage) stored blood is available8-14. Previous studies have demonstrated the
negative consequences of excessive iron availability, in the form of cell free hemoglobin, to
bacteria in sick patients8-14. Given that excess cell free hemoglobin aids in bacterial growth,
washing older stored units of blood prior to transfusion in patients with severe bacterial
infections can help prevent worsening outcome and decrease mortality rates8-14.
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A theorized situation in which washing stored units of blood prior to transfusion may be
beneficial includes transfusion of diabetic patients. To this author’s knowledge, there are no
published studies investigating post-transfusion blood glucose levels of diabetic dogs. This study
demonstrated that, post-storage, there remained high concentrations of glucose within the unit of
blood. Once transfused, that extra glucose has the potential to cause post-transfusion
hyperglycemia in diabetic patients, due to their lack of endogenous insulin. In poorly regulated
diabetics with polyuria, polydipsia, electrolyte abnormalities, and increased risk of infections,
washing stored blood prior to transfusion may significantly reduce the amount of excess glucose
transfused into these patients, and may be of clinical benefit.
Other patients described in human medicine that may benefit from washing of stored red
blood cells prior to transfusion include trauma patients (to reduce the risk of multiple organ
failure15), pediatric patients undergoing cardiac bypass16-18, pediatric patients requiring multiple
transfusions19, and humans with IgA deficiencies20. Research into the translation of these
conditions into veterinary patients in general, and dogs in particular, is lacking. However, since
older stored canine blood has been implicated in the etiology of hemolytic transfusion reactions
and non-hemolytic transfusion reactions21,22, washing cells prior to transfusion may be a method
of reducing these transfusion reactions, and so further research is indicated.
Washing of stored canine red cells prior to transfusion can provide several therapeutic
benefits but, as demonstrated by Solomon et al., not all patients require washing of stored
blood23. In some patients, like those experiencing hemorrhagic shock, transfusion of older nonwashed blood reduced mortality rates and improved vascular function compared to younger
blood23. Future studies are needed to explore the clinical impact of washing stored blood prior to
transfusing in patients experiencing various illnesses.
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A focus of newer studies in transfusion medicine is exploration of transfusion-associated
immunomodulation24. The mechanisms of immunomodulation associated with transfusions is not
well characterized, but storage lesions including cytokines, persistent leukocytes and platelets,
and neutrophil extracellular traps are thought to play key roles24-27. While not a focus of this
study, leukoreduction has been the primary method of reducing immunomodulatory effects of
transfused stored blood28-32. It is possible that washing stored blood may also aid in reducing
some of these immunomodulatory effects. Moreover, the combined effects of leukoreduction and
cell washing have not been explored in canine transfusion medicine and, together, they may even
more effectively reduce storage lesions and potential immunomodulation. Further research in this
area is needed.
The study described in this thesis successfully demonstrated the reduction of storage
lesions in canine red cell units through the use of a manual washing technique. The washing of
stored blood prior to transfusion may have many as yet unexplored benefits, and future research
opportunities in this area are boundless.
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